The list below highlights select publications citing the Sendai virus vectors which are part of the CytoTune-iPS Sendai Reprogramming Kits.

No records were found matching your criteria

YearReprogrammed cell typeReferenceSpecies
2020Blood cellsDeslauriers A.G., et al. (2021) Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells. In: Cobaleda C., Sánchez-García I. (eds) Leukemia Stem Cells. Methods in Molecular Biology, vol 2185. Humana, New York, NYHuman
2020Cells from placental artery endothelium (PL)Isono, W. et al. (2020) The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions. Regenerative Therapy Vol 15 December 2020, Pages 161-168Human
2020CD34+ bone marrow cellsLee, S.-J et al. (2020) Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium. Data in Brief Vol 32 October 2020, 106140Human
2020FibroblastVasylovska, S. et al. Generation of human induced pluripotent stem cell (iPSC) lines (UUMCBi001-A, UUMCBi002-A) from two healthy donors. Stem Cell Res 9 December 2020, 102114 (online)Human
2020PMBCLim, SW. et al. (2020) Generation of a human induced pluripotent stem cell line (CMCi002-A) from a patient with Gitelman’s syndrome. Stem Cell Res 4 December 2020, 102110 (online)Human
2020PMBCChu, E.P-F. et al. (2020) Generation of three induced pluripotent stem cell lines from type 2 diabetic patients with ocular complications. Stem Cell Res Vol 49 December 2020, 102109Human
2020PMBCBarnabei, L. et al. (2020) Generation of an iPSC line (IMAGINi011-A) from a patient carrying a STING mutation. Stem Cell Res 2 December 2020, 102107 (online) Human
2020PBMCBarbeau, S. et al. (2020) Generation of a human induced pluripotent stem cell line (iPSC) from peripheral blood mononuclear cells of a patient with a myasthenic syndrome due to mutation in COLQ. Stem Cell Res Vol 49 December 2020, 102106Human
2020FibroblastBono, F. et al. (2020) Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression. Stem Cell Res Vol 49 December 2020, 102104Human
2020FibroblastDing, Y. et al. (2020) Derivation of iPSC lines from three young healthy donors of Caucasian origin (NUIGi035-A; NUIGi036-A; NUIGi037-A). Stem Cell Res Vol 49 December 2020, 102101Human
2020PBMCYamasaki, AE. et al. (2020) An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects. Stem Cell Res Vol 49 December 2020, 102096Human
2020PBMCSouidi, M. et al. (2020) Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). Stem Cell Res Vol 49 December 2020, 102094Human
2020PBMCYan, R. et al. (2020) Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene. Stem Cell Res Vol 49 December 2020, 102091Human
2020PBMCZhu, YJ. et al. (2020) Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem Cell Res 49 December 2020, 102088Human
2020Urine cellsGuo, X et al. (2020) Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient. Stem Cell Res Vol 49 December 2020, 102085Human
2020FibroblastMukherjee, S. et al. (2020) Generation of human control iPSC line CHOPi004-A from juvenile foreskin fibroblast cells. Stem Cell Res Vol 49 December 2020, 102084Human
2020FibroblastScalise, S. et al. (2020) Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene. Stem Cell Res Vol 49 December 2020, 102083Human
2020FibroblastInglés-Ferrándiz, M. et al. (2020) Generation, establishment and characterization of a pluripotent stem cell line (CVTTHi001-A) from primary fibroblasts isolated from a patient with activated PI3 kinase delta syndrome (APDS2). Stem Cell Res 49 December 2020, 102082Human
2020FibroblastSchuster, J. et al. (2020) Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21). Stem Cell Res Vol 49 December 2020, 102081Human
2020PBMCGong, P. et al. (2020) Generation of a human iPSC line from an epileptic encephalopathy patient with electrical status epilepticus during sleep carrying KCNA2 (p.P405L) mutation. Stem Cell Res Vol 49 December 2020, 102080Human
2020FibroblastVölkner, C. et al. (2020) Generation of an iPSC line (AKOSi006-A) from fibroblasts of an NPC1 patient, carrying the homozygous mutation p.I1061T (c.3182 T > C) and a control iPSC line (AKOSi007-A) using a non-integrating Sendai virus system. Stem Cell Res Vol 49 December 2020, 102056Human
2020PBMCBing, S. et al. (2020) Generation of induced pluripotent stem cell GZHMCi002-A from peripheral blood mononuclear cells with APOB mutation. Stem Cell Res Vol 49 December 2020, 102054Human
2020PBMCZhu, S. et al. (2020) Generation of genomic-integration-free human induced pluripotent stem cells and the derived cardiomyocytes of X-linked dilated cardiomyopathy from DMD gene mutation. Stem Cell Res Vol 49 December 2020, 102040Human
2020PBMCMathieu, F. et al. (2020) Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor. Stem Cell Res Vol 49 December 2020, 102037Human
2020CellsSteeg, R. et al. (2020) The EBiSC iPSC bank for disease studies. Stem Cell Res Vol 49 December 2020, 102034Human
2020PBMCLin, H.-Y., et al. (2020) Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene. Stem Cell Res Vol 49 December 2020, 102032Human
2020PBMCOu-Yang, C.-H et al. (2020) Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene. Stem Cell Res Vol 49 December 2020, 102031Human
2020CD34+ bone marrow cellsLee, S.-J. et al. (2020) Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation. Stem Cell Res Vol 49 December 2020, 102030Human
2020PMBCChu, E.P-F. et al. (2020) Establishment of three human induced pluripotent stem cell lines from a type 1 diabetic family harboring sequence variants associated with autoimmunity. Stem Cell Res Vol 49 December 2020, 102029Human
2020FibroblastLuo, F. et al. (2020) Developmental deficits and early signs of neurodegeneration revealed by PD patient derived dopamine neurons. Stem Cell Res Vol 49 December 2020, 102027Human
2020Renal Epithelial CellsSu, J. et al. (2020) Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent. Stem Cell Res Vol 49 December 2020, 102021Human
2020PBMCBozaoglu, K. et al. (2020) Generation of four iPSC lines from Neurofibromatosis Type 1 patients. Stem Cell Res Vol 49 December 2020, 102013Human
2020FibroblastXiu, X. et al. (2020) Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy individuals. Stem Cell Res Vol 49 December 2020, 102011Human
2020FibroblastAli, E. et al. (2020) Generation of induced pluripotent stem cell (iPSC) lines from a Joubert syndrome patient with compound heterozygous mutations in C5orf42 gene. Stem Cell Res Vol 49 December 2020, 102007Human
2020Bone marrow-derived mesenchymal stem cells; Adipose tissue-derived mesenchymal stem cells; Wharton’s Jelly-derived mesenchymal stem cellsAbabneh, N.A et al. (2020) Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton’s jelly samples. Stem Cell Res Vol 49 December 2020, 102000Human
2020FibroblastGe, N. et al. (2020) Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant. Stem Cell Res Vol 49 December 2020, 101997Human
2020FibroblastGe, N. et al. (2020) Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal fibroblasts of a healthy individual. Stem Cell Res Vol 49 December 2020, 101996Human
2020PBMCDatta, I. et al. (2020) Generation of induced pluripotent stem cells (NIMHi002-A and NIMHi003-A) from two sporadic Parkinson's disease patient of East Indian ethnicity. Stem Cell Res Vol 49 December 2020, 101995Human
2020PBMCZhu, X. et al. (2020) Generation of induced pluripotent stem cells (NJDTHi001-A) from a Danon disease child with mutation of c.467 T > G in LAMP2 gene. Stem Cell Res Vol 49 December 2020, 101994Human
2020FibroblastRatti, A. et al. (2020) Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiology of Disease Vol 145 November 2020, 105051Human
2020FibroblastUcuncu, E.,  et al. (2020)  MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia. Nat Commun 11, 6087 (2020)Human
2020FibroblastCastel, G. et al. (2020) Induction of Human Trophoblast Stem Cells from Somatic Cells and Pluripotent Stem Cells. Volume 33, Issue 8, 24 November 2020, 108419Human
2020Epidermal KeratinocytesChang, YH. et al. (2020) Induced Pluripotent Stem Cell-Differentiated Chondrocytes Repair Cartilage Defect in a Rabbit Osteoarthritis Model. Stem Cell International, 10 November 2020Human
2020FibroblastsSmirnikhina, SA. et al. (2020) P.F508del editing in cells from cystic fibrosis patients. PLoS ONE 15(11): e0242094.Human
2020CD34+ bone marrow cellsTan, C. et al. (2020) Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5′-UTR of the ANKRD26 gene. Stem Cell Res Vol 48 October 2020, 102002Human
2020Myoblasts & PBMCMetzler, E. et al. (2020) Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor. Stem Cell Res Vol 48 October 2020, 101998Human
2020PBMCVaidyanath, A. et al. (2020) Establishment of integration free iPSC clones, NCCSi011-A and NCCSi011-B from a liver cirrhosis patient of Indian origin with hepatic encephalopathy. Stem Cell Res Vol 48 October 2020, 101992Human
2020PBMCAqel, Y. et al. (2020) Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene. Stem Cell Res Vol 48 October 2020, 101991Human
2020CD34+ cells (from PBMC)Sahabian, A. et al. (2020) Generation of two hiPSC clones (MHHi019-A, MHHi019-B) from a primary ciliary dyskinesia patient carrying a homozygous deletion in the NME5 gene (c.415delA (p.Ile139Tyrfs*8)). Stem Cell Res Vol 48 October 2020, 101988Human
2020Myoblasts & PBMCMetzler, E. et al. (2020) Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor. Stem Cell Res Vol 48 October 2020, 101987Human
2020FibroblastRolova, T. et al. (2020) Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer’s disease. Stem Cell Res Vol 48 October 2020, 101968Human
2020FibroblastAbabneh, N.A et al. (2020) Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene. Stem Cell Res Vol 48 October 2020, 101967Human
2020PBMCLiu, S. et al. (2020) Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual. Stem Cell Res Vol 48 October 2020, 101966Human
2020FibroblastZhou, D. et al. (2020) Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation. Stem Cell Res Vol 48 October 2020, 101965Human
2020PBMCSequiera, G.L et al. (2020) Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene. Stem Cell Res Vol 48 October 2020, 101964Human
2020PBMCQuelennec, E. et al. (2020) Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors. Stem Cell Res Vol 48 October 2020, 101959Human
2020FibroblastsRatnavadivel, S. et al. (2020) Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L. Stem Cell Res Vol 48 October 2020, 101957Human
2020FibroblastWang, W. et al. (2020) Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease. Stem Cell Res Vol 48 October 2020, 101937Human
2020PBMCBanal, C. et al. (2020) Generation of an iPSC line (IMAGINi022-A) from a patient carrying a SOX10 missense mutation and presenting with deafness, depigmentation and progressive neurological impairment. Stem Cell Res Vol 48 October 2020, 101936Human
2020PBMCSequiera, G.L et al. (2020) Establishment of variant free-iPSC (UOMi003-A) line from patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Stem Cell Res Vol 48 October 2020, 101935Human
2020PBMCSequiera, G.L et al. (2020) Generation of human induced pluripotent stem cell (hiPSC) line UOMi001-A from a patient with Leigh-like syndrome harbouring compound heterozygous variants in ECHS1 gene. Stem Cell Res Vol 48 October 2020, 101934Human
2020FibroblastKondrateva, E. et al. (2020) Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation. Stem Cell Res Vol 48 October 2020, 101933Human
2020Umbilical cord bloodLu, JZ. et al. (2020) An induced pluripotent stem cell line (EHTJUi002-A) derived from a neonate with c.678G>A mutation in the gene FZD4 causing exudative vitreoretinopathy. Stem Cell Res Vol 48 October 2020, 101932Human
2020FibroblastCosset, E. et al. (2020) Generation of human induced pluripotent stem cell line UNIGEi003-A from skin fibroblasts of an apparently healthy male donor. Stem Cell Res Vol 48 October 2020, 101928Human
2020FibroblastBeh, ST. et al. (2020) Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research. Cells 2020, 9, 2383 (30 October 2020)Human
2020FibroblastRamos-Gonzalez, P. et al. (2020) Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation. Research SquareHuman
2020CellsMcQuade, A., et al. (2020) Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease. Nat Commun 11, 5370 (2020)Human
2020FibroblastBeltran, A. A., et al. (2020). Derivation of Induced Pluripotent Stem Cells from Human Fibroblasts Using a Non-integrative System in Feeder-free Conditions. Bio-protocol 10(20): e3788.Human
2020FibroblastOh, KJ. et al. (2020) Derivation of induced pluripotent stem cell lines from New Zealand donors, Journal of the Royal Society of New Zealand 18 October 2020Human
2020T-cellsAkamine S, et al. (2020) GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons. The FASEB Journal. 2020;34:16601–16621Human
2020FibroblastUrresti, J. et al. (2020) Cortical Organoids Model Early Brain Development Disrupted by 16p11.2 Copy Number Variants in Autism. bioRxiv, 6 October 2020Human
2020FibroblastPedrosa, CDSG. et al. (2020) Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres. Preprint. bioRxiv. 2020;2020.09.11.293951. Published 2020 Oct 9. Human
2020FibroblastTobias, I. et al. (2020) Targeted expression profiling reveals distinct stages of early canine fibroblast reprogramming are regulated by 2-oxoglutarate hydroxylases. Research SquareCanine
2020Prostate cancer cellsZhang, Y. et al. (2020) Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research. Cellular Reprogramming Vol 22, No 5, 30 Sept 2020Human
2020FibroblastsShibamiya, A. et al. (2020). Cell banking of hiPSCs: A practical guide to cryopreservation and quality control in basic research. Current Protocols in Stem Cell Biology, 55, e127Human
2020Cells from fetal lung tissueKunisaki, SM et al. (2020) Human induced pluripotent stem cell‐derived lung organoids in an ex vivo model of the congenital diaphragmatic hernia fetal lung. Fetal and Neonatal Stem Cells 19 Sept 2020Human
2020CellsKumar, M et al. (2020) Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons. Volume 15, Issue 3, 8 September 2020, Pages 629-645Human
2020CellsHuang, CY. et al. (2020) Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank. J Biomed Sci 27, 92 (2020).Human
2020FibroblastKohama, Y. et al. (2020) Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes. Sci Rep 10, 15348 (2020Human
2020FibroblastCowan, C.S. et al. (2020) Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution. Volume 182, Issue 6, 17 September 2020, Pages 1623-1640.e34Human
2020FibroblastPatel, A. et al. (2020) Establishment and characterization of two iPSC lines derived from healthy controls. Stem Cell Res Vol 47 August 2020, 101926Human
2020FibroblastAbabneh, N.A et al. (2020) Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene. Stem Cell Vol 48 October 2020, 101925Human
2020FibroblastAbabneh, N.A et al (2020) Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi011-A) from skin fibroblasts of a healthy Jordanian male subject. Stem Cell Res Vol 48 October 2020, 101923Human
2020FibroblastTobias, I. et al. (2020) Targeted expression profiling reveals distinct stages of early canine fibroblast reprogramming are regulated by 2-oxoglutarate hydroxylases. Research SquareCanine
2020FibroblastsKlofas, LK et al. (2020) DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons. Neurobiology of Disease, Vol 143 September 2020, 104975Human
2020FibroblastsChen D, et al (2020) Human induced pluripotent stem cells generated from a patient with a homozygous L272P mutation in the OTULIN gene (NIHTVBi014-A). Stem Cell Res Vol 47 August 2020, 101921Human
2020PBMCChen X, et al (2020) An iPSC line (TYWHSTi002-A) derived from a patient with Pendred syndrome caused by compound heterozygous mutations in the SLC26A4 gene. Stem Cell Res Vol 47 August 2020, 101919Human
2020PBMCVallejo-Diez S, et al (2020) Generation of one iPSC line (IMEDEAi007-A) by Sendai Virus transduction of PBMCs from a Psoriasis donor. Stem Cell Res Vol 47 August 2020, 101917Human
2020PBMCNiu S, et al (2020) Generation of patient-specific induced pluripotent stem cells (ZZUSAHi001-A) derived from a familial atrial fibrillation patient carrying KCNA5 c.775G>A mutation. Stem Cell Res Vol 47, August 2020, 101915Human
2020CD 34+Lee SJ, et al (2020) Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium. Stem Cell Res Vol 47 August 2020, 101913Human
2020PBMCZhang Y, et al (2020) Generation of two induced pluripotent stem cell lines (XACHi0010-A, XACHi0011-A) from a Chinese family with combined oxidative phosphorylation deficiency carrying homozygous and heterozygous C1QBP-L275F mutation. Stem Cell Res Vol 47 August 2020, 101912Human
2020CD4+ T-cellsVaidyanath A, et al (2020) Development and characterization of two independent integration free iPSC clones NCCSi010-A and NCCSi010-B from a patient with alcoholic liver cirrhosis of Indian ethnicity. Stem Cell Res Vol 47 August 2020, 101911Human
2020PBMCFukunaga I, et al (2020) Generation of two induced pluripotent stem cell lines from PBMCs of siblings carrying c.235delC mutation in the GJB2 gene associated with sensorineural hearing loss. Stem Cell Res Vol August 2020, 101910Human
2020FibroblastAbabneh, N.A. et al. (2020) Establishment of (JUCTCi007-A) iPSC line from a patient with congenital myasthenic syndrome (CMS) carrying a homozygous mutation p.Arg331Trp (c.991C > T) in the CHRNE gene. Stem Cell Res Vol 47 August 2020, 101906Human
2020PBMCYan, Y. et al. (2020) Generation of a human iPSC line CIBi007-A from a patient with young-onset Parkinson’s disease carrying variants in PRKN and HTRA2. Stem Cell Vol Vol 47 August 2020, 101905Human
2020PBMCRebs, S. et al. (2020) Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation. Stem Cell Res Vol 47 August 2020, 101901Human
2020PBMCNengqing L, et al (2020) Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation. Stem Cell Res Vol 47 August 2020, 101897Human
2020PBMCPerepelina, K et al (2020) Generation of two iPSC lines (FAMRCi007-A and FAMRCi007-B) from patient with Emery–Dreifuss muscular dystrophy and heart rhythm abnormalities carrying genetic variant LMNA p.Arg249Gln. Stem Cell Res Vol 47 August 2020, 101895Human
2020CellsSinha et al. (2020) Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy, The American Journal of Human Genetics August 6, 2020Human
2020CellsWarre-Cornish, K. et al. (2020) Interferon-γ signaling in human iPSC–derived neurons recapitulates neurodevelopmental disorder phenotypes. Sci. Adv. 2020; 6 : eaay9506 19 August 2020Human
2020FibroblastMazzara, PG. et al. (2020) Frataxin gene editing rescues Friedreich’s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons. Nat Commun 11, 4178 (2020)Human
2020FibroblastRichard P. et al. (2020) SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation, Autophagy, 7 August 2020Human
2020FibroblastHo, MF. et al (2020) TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. Mol Psychiatry (2020)Human
2020T-cellsLandon, M. et al. (2020) Establishing consistent methods for the generation of donor-derived iPSCs from T cell subsets [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl): Abstract nr 488.Human
2020FibroblastSalikhova, D. et al. (2020) Secretome-Mediated Neuroprotective Effects of the hiPSC-derived Glial and Neuronal Progenitor Cells in the Hypoxia-Induced Neuronal Damage (Comparative Study). Research SquareHuman
2020DPSC (Dental Pulp Stem Cells)Bosch, B. et al. (2020) A new alternative for corneal endothelial regeneration using autologous dental pulp stem cells. Research Square Human
2020Fibroblast, PBMCOlivia Krefft, 30 September 2020: Unraveling the pathology of different disease severities in human cerebral organoid models of LIS1-lissencephaly. DissertationHuman
2020FibroblastSimon Alexander Sumer, 29. September 2020: Deciphering the role of SHOX2 in atrial fibrillation and sinus node dysfunction. DissertationHuman
2020FibroblastAbabneh, NA et al (2020) Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi010-A) from a healthy Jordanian female skin dermal fibroblasts. Stem Cell Res 47 August 101891Human
2020Urine cellsGuo, X et al. (2020) Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation. Stem Cell Res Vol 47 August 101886Human
2020Fibroblast, PBMCSerra-Vinardell, J. et al (2020) Generation and characterization of four Chediak-Higashi Syndrome (CHS) induced pluripotent stem cell (iPSC) lines. Stem Cell Res Vol 47 August 2020, 101883Human
2020FibroblastLi, X. et al. (2020) An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene. Stem Cell Res Vol 47 August 2020, 101882Human
2020Wharton’s jelly stem cells of the umbilical cordKong, CM et al (2020) Tissues derived from reprogrammed Wharton’s jelly stem cells of the umbilical cord as a platform to study gestational diabetes mellitus. Stem Cell Res Vol 47 August 2020, 101880Human
2020PMBCCai, Y et al (2020) Generation of a human induced pluripotent stem cell line (SHUPLi001-A) from PBMCs of a healthy male donor. Stem Cell Res Vol 47 August 2020, 101871Human
2020FibroblastBenabdallah, B., et al. (2020) Myogenic progenitor cells derived from human induced pluripotent stem cell are immune-tolerated in humanized mice. STEM CELLS Transl Med. 2020;1–11Human
2020PBMCMenara, G. et al (2020) Generation of an induced pluripotent stem cell (iPSC) line (IMAGINi007) from a patient with steroid-resistant nephrotic syndrome carrying the homozygous p.R138Q mutation in the podocin-encoding NPHS2 gene. Stem Cell Res Vol 46 July 2020, 101878Human
2020PBMCNa, DH et al (2020) Generation of a human induced pluripotent stem cell line (CMCi001-A) from a patient with karyomegalic interstitial nephritis with homozygous frameshift deletion mutation c.1985_1994del10 of the FANCD2/FANCI-Associated Nuclease 1 gene. Stem Cell Res Vol 46 July 2020, 101876Human
2020PBMCZhang, S.-J. et al (2020) Derivation of an induced pluripotent stem cell line (PUMCHi003-A) from a patient with pulmonary arterial hypertension carrying heterozygous mutation in PTGIS gene. Stem Cell Res Vol 46 July 2020, 101875Human
2020Renal epithelial cellsWang, J. et al (2020) Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson’s disease patient carrying a c.180_181del mutation in ATP7B gene. Stem Cell Res Vol 46 July 2020, 101873Human
2020PBMCWang, A. et al (2020) Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan–Herndon–Dudley syndrome. Stem Cell Res Vol 46 July 2020, 101872Human
2020PBMCChen, J. et al. (2020) Generation of human induced pluripotent stem cell (SKLRMi001-A) from a patient with partial androgen insensitivity syndrome (PAIS). Stem Cell Res Vol 46 July 2020, 101863Human
2020FibroblastsJanz, A. et al. (2020) Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation. Stem Cell Res 46 July 2020, 101856Human
2020FibroblastBuers, I. et al. (2020) Crisponi syndrome/cold-induced sweating syndrome type 2: Reprogramming of CS/CISS2 individual derived fibroblasts into three clones of one iPSC line. Stem Cell Res Vol 46 July 2020, 101855 
2020FibroblastArbini, A et al. (2020) Generation of three induced pluripotent stem cell (iPSC) lines from a patient with developmental epileptic encephalopathy due to the pathogenic KCNA2 variant c.869T>G; p.Leu290Arg (NUIGi052-A, NUIGi052-B, NUIGi052-C). Stem Cell Res Vol 46 July 2020, 101853Human
2020Cord Blood MSCBarilani, M et al. (2020) A circular RNA map for human induced pluripotent stem cells of foetal origin. eBioMedicine Vol 57 July 2020, 102848Human
2020FibroblastSchöning, L. et al. (2020) Generation of induced pluripotent stem cell lines from a Crisponi/Cold induced sweating syndrome type 1 individual. Stem Cell Res Vol 46 July 2020, 101820Human
2020Type 1 Diabetes cellsLeite NC, et al (2020) Modeling Type 1 Diabetes In Vitro using Human Pluripotent Stem Cells. Cell Reports 32, 107894, July 14 2020Human
2020FibroblastWalsh, P. et al. (2020) Accelerated differentiation of human pluripotent stem cells into neural lineages via an early intermediate ectoderm population. Stem Cells Vol 38:1400–1408Human
2020PBMCKim, KY et al (2020) Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients. Transl Neurodegener 9, 23 (2020).Human
2020FibroblastGrønning Hansen, M et al (2020) Grafted human pluripotent stem cell-derived cortical neurons integrate into adult human cortical neural circuitry. STEM CELLS Transl Med. 2020;9:1365–1377.Human
2020PBMCChristidi E, et al (2020) Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes. Scientific Reports | (2020) 10:10363 Human
2020PBMCChristidi, E. et al (2020). Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes. Sci Rep 10, 10363 (2020)Human
2020PBMCSubramani, P et al (2020). Plasmodium vivax liver stage assay platforms using Indian clinical isolates. Malar J 19, 214 (2020).Human
2020FibroblastsDas Sharma, S. et al. (2020) Cortical neurons derived from human pluripotent stem cells lacking FMRP display altered spontaneous firing patterns. Molecular Autism 11, 52 (2020)Human
2020Liver cells (hepatic non-parenchymal)Kirchner VA, et al (2020) Reprogramming of Human Hepatic Non‐Parenchymal Cells: Step‐by‐Step Protocol. Current Protocols in Stem Cell Biology 17 June 2020Human
2020FibroblastStrano, A et al (2020) Variable Outcomes in Neural Differentiation of Human PSCs Arise from Intrinsic Differences in Developmental Signaling Pathways. Cell Reports Vol 31, Issue 10, 9 June 2020, 107732Human
2020FibroblastMorival J, et al (2020) Targeted epigenetic tools for the control of variability in cardiac differentiation of patient-derived iPSCsHuman
2020CD34+ cellsDrick N, et al (2020) Generation of two human induced pluripotent stem cell lines (MHHi017-A, MHHi017-B) from a patient with primary ciliary dyskinesia carrying a homozygous mutation (c.7915C > T [p.Arg2639*]) in the DNAH5 gene. Stem Cell Res Vol 46 July 2020, 101848. Doi.org/10.1016/j.scr.2020.101848Human
2020CD34+ cellsDahlmann, J et (2020) Generation of two hiPSC lines (MHHi016-A, MHHi016-B) from a primary ciliary dyskinesia patient carrying a homozygous 5 bp duplication (c.248_252dup (p.Gly85Cysfs*11)) in exon 1 of the CCNO gene. Stem Cell Res Vol 46 July 2020, 101850. Roi.org/10.1016/j.scr.2020.101850Human
2020KeratinocytesLee H, et al (20202) Apolipoprotein E expression pattern in human induced pluripotent stem cells during in vitro neural induction [version 1; peer review: awaiting peer review]. F1000Research 2020, 9:353 (https://doi.org/10.12688/f1000research.23580.1)Human
2020FibroblastSun C, et al (2020) Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies 3 compounds that ameliorate disease in mdx miceHuman
2020Primary LymphocytesFantuzzo, JA et al (2020) Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications. Lab on a chip, Issue 6, 2020Human
2020FibroblastCollino F, et al (2020) Extracellular Vesicles Derived from Induced pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model. Cells 2020, 9, 453; Doi:10.3390/cells9020453Human
2020FibroblastShen X, et al (2020) Progress towards drug discovery for Friedreich’s Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein. Bioorganic and Medicinal Chemistry Vol 28 Issue 11, 1 June 2020, 115472. Doi.org/10.1016/j.bmc.2020.115472Human
2020CellsHeaton H, et al (2020)  Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat Methods (2020). Doi.org/10.1038/s41592-020-0820-1Human
2020CD34+ cellsLiu H, et al (2020)  Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations. J Neurodevelop Disord 12, 14 (2020) Doi.org/10.1186/s11689-020-09317-2Human
2020FibroblastXian X, et (2020) et al. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells. Stem Cell Res Ther 11, 179 (2020). Doi.org/10.1186/s13287-020-01701-yHuman
2020FibroblastLito S, (2020) In vitro modelling of neural insult in Mucopolysaccharidosis type 1 hurler using patient-derived human induced pluripotent stem cells. Thèse de doctorat : Univ. Genève, 2020, no. Sc. Méd. 38. DOI : 10.13097/archive-ouverte/unige:136222Human
2020PBMCKim, BY et al (2020) Generation of induced pluripotent stem cells (KSCBi009-A) from a patient with Prader–Willi syndrome (PWS) featuring deletion of the paternal chromosome region 15q11.2–q13. Stem Cell Res online 20 May 2020, 101847. Doi.org/10.1016/j.scr.2020.101847Human
2020PBMCMui BWH, et al (2020) Generation of human induced pluripotent stem cell line (NIDCRi001-A) from a Muenke syndrome patient with an FGFR3 p.Pro250Arg mutation. Stem Cell Res online 19 May 2020, 101823. Doi.org/10.1016/j.scr.2020.101823Human
2020PBMCHe R et al (2020)  Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy. Biol Res 53, 22 (2020). Doi.org/10.1186/s40659-020-00288-1Human
2020FibroblastBifari F, et al (2020) Complete neural stem cell (NSC) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism. Pharmacological Res online 12 May 2020, 104863. Doi.org/10.1016/j.phrs.2020.104863Human
2020PBMCWang Y, et al (2020) Induced pluripotent stem cells (SHCDNi002-A cells) isolated from the peripheral blood mononuclear cells of a 1-year-old Chinese girl with mediator complex subunit 12-related syndrome. Stem Cell Res online 8 May 2020, 101838. Doi.org/10.1016/j.scr.2020.101838Human
2020FibroblastHan MJ, et al (2020) Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations. Stem Cell Research online 6 May 2020, 101836 Doi.org/10.1016/j.scr.2020.101836. Human
2020FibroblastXiang L, et (2020)  et al. Role of Chromatin Remodeling Genes and TETs in the Development of Human Midbrain Dopaminergic Neurons. Stem Cell Rev and Rep (2020). https://doi.org/10.1007/s12015-020-09972-xHuman
2020PBMCAli M, et al (2020)Generation and proteome profiling of PBMC-originated, iPSC-derived lentoid bodies. Stem Cell Res online 5 May 2020, 101813. Doi.org/10.1016/j.scr.2020.101813Human
2020PBMCFeng B, et al (2020) Induced pluripotent stem cell line derived from a sporadic amyotrophic lateral sclerosis patient. Stem Cell Res Vol 45 May 2020, 101841. Foi.org/10.1016/j.scr.2020.101841Human
2020FibroblastSun L, et al (2020) Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene. Stem Cell Res Vol 45 May 2020, 101833. Doi.org/10.1016/j.scr.2020.101833Human
2020PBMCYuan F, et al (2020) Generation of an induced pluripotent stem cell line SHCDNi001-A from a one-year-old Chinese girl with mitochondrial DNA depletion syndrome 13. Stem Cell Res Vol 45 May 2020, 101832. Doi.org/10.1016/j.scr.2020.101832Human
2020FibroblastOitari LE, et al (2020) Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery. Stem Cell Reports Vol. 14 924–939 May 12, 2020. Doi.org/10.1016/j.stemcr.2020.03.011Human
2020PBMCHuang CY, et al (2020) Establishment of an induced pluripotent stem cell (iPSC) line from a 7-year-old male patient with profound hearing loss carrying c.235delC in GJB2 gene. Stem Cell Res Vol 45 May 2020, 101795. Doi.org/10.1016/j.scr.2020.101795Human
2020KeratinocytesKhurana P, et al (2020) Stem Cell Research Lab Resource: Stem Cell LineInduced pluripotent stem cell (iPSC) line MLi-003A derived from an individual with the maximum number of filaggrin (FLG) tandem repeats. Stem Cell Res Vol 45 May 2020, 101827. Roi.org/10.1016/j.scr.2020.101827Human
2020PBMCChen G, et al (2020) Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation. Stem Cell Res Vol 45 May 2020, 101821. Doi.org/10.1016/j.scr.2020.101821Human
2020PMBCYan Y, et al (2020) Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene. Stem Cell Res 45 May 2020, 101792. Doi.org/10.1016/j.scr.2020.101792Human
2020PBMCZhang Y, et al (2020) Generation of three iPSC lines (XACHi007-A, XACHi008-A, XACHi009-A) from a Chinese family with long QT syndrome type 5 with heterozygous c.226G>A (p.D76N) mutation in KCNE1gene. Stem Cell Res Vol 45 May 2020, 101798 Doi.org/10.1016/j.scr.2020.101798Human
2020PBMCLiu CL et al (2020) Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res Vol 45 May 2020, 101784. Doi.org/10.1016/j.scr.2020.101784Human
2020FibroblastCiolak A, et al (2020) Generation of human iPS cell line IBCHi002-A from spinocerebellar ataxia type 3/Machado-Joseph disease patient's fibroblasts. Stem Cell Res Vol 45 May 2020, 101796. Doi.org/10.1016/j.scr.2020.101796Human
2020Blood cellsVaidyanath A, et al (2020) Generation of two control iPSC clones NCCSi008-A and NCCSi008-B from an individual of Indian ethnicity. Stem Cell Res Vol 45 May 2020, 101765 Doi.org/10.1016/j.scr.2020.101765Human
2020CellsTang L, et al (2020) Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus Vol 142 J. of Molecular and Cellular Cardiology May 2020, Pages 53-64. Doi.org/10.1016/j.yjmcc.2020.03.016Human
2020FibroblastLarsen SB, et al (2020) Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35. Stem Cell Res Vol 45 May 2020, 101776. Doi.org/10.1016/j.scr.2020.101776Human
2020FibroblastChen M, et al (2020) Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation. Stem Cell Res Vol 45 May 2020, 101781. Doi.org/10.1016/j.scr.2020.101781Human
2020CellsGenova E, et al (2020) Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients. Doi.org/10.1002/cpt.1837Human
2020FibroblastKnottnerus SJG et al (2020) Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates. Int. J. Mol. Sci. 2020, 21, 2589. Doi.org/10.3390/ijms21072589Human
2020FibroblastTrembinski D.J  et al (2020) . Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction. Nat Commun 11, 2039 (2020). Doi.org/10.1038/s41467-020-15995-2Human
2020CellsWarre-Cornish K, et al (2020) IFNγ signalling alters neurodevelopment. bioRxiv preprint , April 21 2020. Doi.org/10.1101/789321. Human
2020FibroblastMun SJ, et al (2020) Long-Term Expansion of Functional Human Pluripotent Stem Cell-Derived Hepatic Organoids. International Journal of Stem Cells Published online April 30, 2020Human
2020CD34+ cellsSecardin L, et al (2020) TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells. Stem Cel Res Vol 44, April 2020, 101755. Doi.org/10.1016/j.scr.2020.101755Human
2020FibroblastYang M, et al (2020) Generation of twelve induced pluripotent stem cell lines from two healthy controls and two patients with sporadic amyotrophic lateral sclerosis. Stem Cell Res Vol 44 April 2020, 101752 Doi.org/10.1016/j.scr.2020.101752Human
2020Blood cellsDatta I, et al (2020) Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant. Stem Cell Res Vol 44, April 2020, 101768. Doi.org/10.1016/j.scr.2020.101768Human
2020FibroblastHuo Y, et al (2020) Establishment of human induced pluripotent stem cell line from dermal fibroblasts of a healthy individual. Stem Cell Res Vol 44, April 2020, 101762. doi.org/10.1016/j.scr.2020.1017622020Human
2020FibroblastSlot E, et al (2020) Generation of three iPSC lines from two patients with heterozygous FOXF1 mutations associated to Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins. Stem Cell Res Vol 44, April 2020, 101745. Doi.org/10.1016/j.scr.2020.101745Human
2020FibroblastLi R, et al (2020) An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene. Stem Cell Res April 2020, 101737. Doi.org/10.1016/j.scr.2020.101737Human
2020FibroblastBchetnia M, et (2020) Generation of a human induced pluripotent stem cell line (UQACi001-A) from a severe epidermolysis bullosa simplex patient with the heterozygous mutation p.R125S in the KRT14 gene. Stem Cell Res Vol 44, April 2020, 101748. Doi.org/10.1016/j.scr.2020.101748Human
2020Blood cellElsayad AK, et al (2020) Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene. Stem Cell Res Vol 44, April 2020, 101736Human
2020PBMCLin HY, et al (2020) Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene. Stem Cell Res Vol 44, April 2020, 101734. Doi.org/10.1016/j.scr.2020.101734Human
2020FibroblastShuvalova LD, et (2020) Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene. Stem Cell Res Vol 44, April 2020, 101733. doi.org/10.1016/j.scr.2020.101733Human
2020MSCPichard L, et al (2020) Generation of human pluripotent stem cell lines (iPSCs) from mesenchymal stem cells (MSCs) from three elderly patients with osteoarthritis. Stem Cell Res Vol 44 April 2020, 101721. Doi.org/10.1016/j.scr.2020.101721Human
2020FibroblastOji Y, et al (2020) Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain, Volume 143, Issue 4, April 2020, Pages 1190–1205.Human
2020MyoblastsKatarzyna F, et al (2020) Tissue-specifc promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes. Scientific Reports (Nature Publisher Group); London Vol. 10, Iss. 1, (2020). DOI:10.1038/s41598-020-58050-2Human
2020FibroblastPerenthaler E, et al (2020) Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi‑allelic isoform‑specific start‑loss mutations of essential genes can cause genetic diseases. Acta Neuropathologica (2020) 139:415–442,. DOI:10.1007/s00401-019-02109-6Human
2020FibroblastTete G, et al (2020) New Application of Osteogenic Differentiation from HiPS Stem Cells for Evaluating the Osteogenic Potential of Nanomaterials in Dentistry. Int. J. Environ. Res. Public Health 2020, 17, 1947. Doi:10.3390/ijerph17061947Human
2020FibroblastStrah, N., Romano, G., Introna, C. et al. TDP-43 promotes the formation of neuromuscular synapses through the regulation of Disc-large expression in Drosophila skeletal muscles. BMC Biol 18, 34 (2020). Doi.org/10.1186/s12915-020-007 
2020FibroblastLi X, et (2020) Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7. Stem Cell Res Vol 43 March 2020, 101699. Doi.org/10.1016/j.scr.2020.101699Human
2020PBMCFuchs N, et al (2020) Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi–Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1). March 2020, 101697. Doi.org/10.1016/j.scr.2019.101697Human
2020CellsAlmedawar S, et al (2020) MERTK-Dependent Ensheathment of Photoreceptor Outer Segments by Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium. Stem Cell Reports j Vol. 14 j 374–389. Doi.org/10.1016/j.stemcr.2020.02.004Human
2020FibroblastCastro-Viñuelas R, et al (2020) Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts. Scientific Reports 10, Article number: 4272, March 6, 2020Human
2020FibroblastMilagre I, et al(2020) Reprogramming of Human Cells to Pluripotency Induces 2 CENP-A Chromatin Depletion. Doi.org/10.1101/2020.02.21.960252. Human
2020FibroblastAkkouh IA, et al (2020) Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells. Brain, Behavior, and Immunity, 25 Feb. 2020. Doi.org/10.1016/j.bbi.2020.02.008Human
2020CellsLegoy TA, et al (2020). In vivo Environment Swiftly Restricts Human Pancreatic Progenitors Toward Mono-Hormonal Identity via a HNF1A/HNF4A Mechanism. Cell Dev. Biol., 25 February 2020. Doi.org/10.3389/fcell.2020.00109Human
2020FibroblastJung ES, et al (2020) Successful Correction of ALD Patient-derived iPSCs Using CRISPR/Cas9. bioRxiv Feb. 25, 2020. Doi.org/10.1101/2020.02.23.962118. Human
2020FibroblastRLW Lau, et al (2020) Percutaneous intrarenal transplantation of differentiated induced pluripotent stem cells into newborn mice. American Association for Anatomy 11 Feb, 2020 Doi.org/10.1002/ar.24371Mouse
2020FibroblastZhu, W. et al (2020). Transplantation of iPSC-TM stimulates division of trabecular meshwork cells in human eyes. Sci Rep 10, 2905 (2020). Doi.org/10.1038/s41598-020-59941-0Human
2020Myeloid CellsForbester JL, et al (2020) IRF5 promotes influenza-induced inflammatory responses in human iPSC-derived 2 myeloid cells and murine models. J. Virol. Doi:10.1128/JVI.00121-20Human
2020PBMCEichmueller OL, et al (2020) Cerebral organoid model reveals excessive proliferation of human 4 caudal late interneuron progenitors in Tuberous Sclerosis Complex. bioRxiv preprint Feb.27, 2020. Doi.org/10.1101/2020.02.27.967802. Human
2020MyoblastsFiedorowicz K, et al (2020). Tissue-specific promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes. Sci Rep 10, 1895 (2020).Human
2020FibroblastRatti A, et al. (2020)Induction of Chronic Stress Reveals an Interplay of Stress Granules and TDP-43 Pathological Aggregates in Human Als Fibroblasts and iPSC-Neurons. bioRxiv, Feb. 17, 2020. Doi.org/10.1101/2020.02.17.951434. Human
2020Urine cellsRobinett JC, et al (2020) Step Stretches and Shortenings Elicit Similar Transient Force Overshoots. Biophysical Journal, Vol. 118, ISSUE 3, SUPPLEMENT 1, 279A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1595Human
2020Urine cellsRynkiewicz MJ, et al (2020) Molecular Dynamics Simulations of Alpha-Beta-Tropomyosin Show Conformational Properties of Heterodimeric Tropomyosin. Biophysical Journal Vol.118, ISSUE 3, SUPPLEMENT 1, 279A-280A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1598Human
2020Urine cellsLindqvist J, et al (2020) Mutations in the Large Protein Nebulin Trigger Typical Nemaline Myopathy with a Unique Molecular Mechanism. Biophysical Journal, Vol. 118, ISSUE 3, SUPPLEMENT 1, 279A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1597Human
2020Urine cellsRahmani H, Insights into Various Types of Myopathy using the Atomic Model of Lethocerus Myosin Filaments. Biophysical Journal, Vol/ 118, ISSUE 3, SUPPLEMENT 1, 279A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1596Human
2020Urine cellsLuttrell S, et al (2020) Use of Cells from Remotely Collected Urine to Generate Human Induced Pluripotent Stem Cells and Myofibers that Recapitulate Unconventional Myopathies. Biophysical Journal, Vol 118, ISSUE 3, SUPPLEMENT 1, 278A-279A, FEBRUARY 07, 2020 Doi.org/10.1016/j.bpj.2019.11.1594Human
2020Dendritic Cells (DC)Horton C, et al (2020) Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Stem Cells 2020 Jan; 38(1): 67–79. doi: 10.1002/stem.3095Mouse
2020Cord BloodAraki, R, et al (2020). Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency. Nat Commun 11, 197 (2020). Doi.org/10.1038/s41467-019-13830-Human
2020Primary culture of prostate organoidsHepburn A, et al (2020) Propagation of human prostate tissue from induced pluripotent stem cells. STEM CELLS Transl Med. 2020;1–12. DOI: 10.1002/sctm.19-0286Human
2020PBMCBardelli D, et al (2020) Reprogramming fibroblasts and peripheral blood cells from a C9ORF72 patient: A proof-of-principle study. 21 January 2020. J Cell Mol Med. 2020;24:4051–4060. DOI: 10.1111/jcmm.15048 Human
2019FibroblastBartusel M, (Ph.D thesis)DISRUPTION OF NEURAL CREST ENHANCER LANDSCAPES AS AN ETIOLOGICAL MECHANISM FOR HUMAN NEUROCRISTOPATHIES. Dec. 2019Human
2019FibroblastRen C, et al (2020) A compendious summary of Parkinson’s disease patient-derived iPSCs in the first decade. Ann Transl Med. 2019 Nov; 7(22): 685.Doi: 10.21037/atm.2019.11.16Human
2020FibroblastRodriguez-Traver E, et al (2010) A collection of three integration-free iPSCs derived from old male and female healthy subjects. Stem Cell Res Vol 42 January 2020, 101663. Doi.org/10.1016/j.scr.2019.101663Human
2020PBMCLanzi G, et al (2019) Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene. Stem Cell Res Vol 42 January 2020, 101660. Doi.org/10.1016/j.scr.2019.101660Human
2019Primary CellsDraper J.M., Vivian J.L. (2020) Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus. In: Larson M. (eds) Transgenic Mouse. Methods in Molecular Biology, vol 2066. Humana, New York, NY. Human
2019FibroblastFuellgrabe A, et al (2019) Guidelines for reporting single-cell RNA-Seq experimentsHuman
2019CellsLewallen CF, et al (2019) High-yield, automated intracellular electrophysiology in retinal pigment epithelia. Journal of Neuronal Science, Vol 328, 1 December 2019, 108442. Doi.org/10.1016/j.jneumeth.2019.108442Human
2019PBMCGao X, et al (2019) Establishment of induced pluripotent stem cell line (GSPHi001-A) from a 6-year old female with nephrotic syndrome. Stem Cell Res Vol 41 December 2019, 101661. Doi.org/10.1016/j.scr.2019.101661Human
2019FibroblastUebacher C et al (2019) Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons. Stem Cell Res Vol 41 December 2019, 101656. Doi.org/10.1016/J.scr.2019.101656Human
2019FibroblastDing Y, et al (2019) Derivation of familial iPSC lines from three ASD patients carrying NRXN1α+/– and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A, NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B; NUIGi026-A, NUIGi026-B). Stem Cell Res Vol 41 December 2019, 101653 Doi.org/10.1016/j.scr.2019.101653Human
2019FibroblastGe N, et al (2019) Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation. Stem Cell Res Vol 41 December 2019, 101650. Doi.org/10.1016/j.scr.2019.101650Human
2019PBMCPark H, et al (2019) Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells of a Senior-Loken syndrome patient. Stem Cell Res Vol 41 December 2019, 101648. Doi.org/10.1016/j.scr.2019.101648Human
2019PBMCKim BY et al (2019) Generation of patient-specific induced pluripotent stem cells (KSCBi007-A) derived from a patient with Prader–Willi syndrome retain maternal uniparental disomy (UPD). Stem Cell Res Vol 41 December 2019, 101647. Doi.org/10.1016/j.scr.2019.101647Human
2019FibroblastLai X, et al (2019) Generation of an induced pluripotent stem cell line (SYSUi002-A) from a patient with coronary slow flow phenomenon. Stem Cell Res Vol 41 December 2019, 101646. Doi.org/10.1016/j.scr.2019.101646Human
2019FibroblastDulovic-Mahlow M, et al (2019) Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's disease. Stem Cell Res Vol 41 December 2019, 101629. Doi.org/10.1016/j.scr.2019.101629Human
2019PBMCPatterson K, et al (2019) Generation of two induced pluripotent stem cell lines (NHLBIi001-A and NHLBIi001-B) from a healthy Caucasian female volunteer with normal cardiac function. Stem Cell Res Vol 41 December 2019, 101627. Doi.org/10.1016/j.scr.2019.101627Human
2019FibroblastMartinez-Turrillas R, et al (2019) Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene. Stem Cell Res Vol 41 December 2019, 101626, doi.org/10.1016/j.scr.2019.101626Human
2019FibroblastWohlschlegel J, et al (2019) Generation of human induced pluripotent stem cell lines from a patient with ITM2B-related retinal dystrophy and a non mutated brother. Stem Cell Res Vol 41 December 2019, 101625. Doi.org/10.1016/j.scr.2019.101625Human
2019FibroblastMasneri S, et al (2019) Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene. Stem Cell Res Vol 41 December 2019, 101623. Doi.org/10.1016/j.scr.2019.101623Human
2019PBMCKim BY, et al (2019) Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation. Stem Cell Res Vol 41 December 2019, 101622. Doi.org/10.1016/j.scr.2019.101622Human
2019PBMCZhang Y, et al (2019) Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene. Stem Cell Res Vol 41 December 2019, 101621. Doi.org/10.1016/j.scr.2019.101621Human
2019FibroblastsLito S, et al (2019) Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease. Stem Cell Res Vol 41 December 2019, 101604. Doi.org/10.1016/jscr.2019.101604Human
2019PBMCLamolda M, et al (2019) GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant. Stem Cell Res, Vol 41, December 2019, 101603. Doi.org/10.1016/j.scr.2019.101603Human
2019PBMCMasneri S, et al (2019) Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene. Stem Cell Res Vol 41 December 2019, 101596. Doi.org/10.1016/j.scr.2019.101596Human
2019FibroblastDuarte AJ et al (2019) Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene. Stem Cell Res Vol 41 December 2019, 101595.Doi.org/10.1096/j.scr.2019.101595Human
2019PBMCFuchs NV, et al (2019) Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A). Stem Cell Res, Vol 41 December 2019, 101592. Doi.org/10.1016/j.scr.2019.101592Human
2019Epidermal KeratinocytesShrestha R, et al (2019) Generation of hiPSC line TCIERi001-A from normal human epidermal keratinocytes. Stem Cell Res Vol 41, December 2019, 101590. Doi.org/10.1016/j.scr.2019.101590Human
2019FibroblastDiaz-Guerra E, et al (2019) An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer's disease patient with the APOE-_4/_4 alleles. Stem Cell Res, Vol 41, December 2019, 101588. Doi.org/10.1016/j.scr.2019.101588Human
2019Bone barrow CellsYamasaki A, et al (2019)T wo iPSC lines generated from the bone marrow of a relapsed/refractory AML patient display normal karyotypes and myeloid differentiation potential. Stem Cell Res Vol 41 December 2019, 101587. Doi.org/10.1016/j.scr.2016.101587Human
2019PBMCYingjun X, et al (2019) Generation of four induced pluripotent stem cell lines, GZWWTi001-A, GZWTZi001-A, GZWXYi001-A, and GZWXDi001-A, derived from peripheral blood mononuclear cells from a family with asparagine synthetase deficiency. Stem Cell Res Vol 41 December 2019, 101583. Doi.org/10.1016/j.scr.2019.101583Human
2019FibroblastFerraro RM, et al (2019) Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1. Stem Cell Res, Vol 41, December 2019, 101580. Doi.org./10.1016.j.scr.2019.101580Human
2019FibroblastSchuster J, et al (219) Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment. Neurobiology of Disease, Vol 132, December 2019, 104583. doi.org/10/1016.j.nbd.2019.104583 Human
2019Cells from the amniotic fluidSung TC, et al (2019) Effect of cell culture biomaterials for completely xeno-free generation of human induced pluripotent stem cells. Biomaterials 25 November 2019, 119638. Doi.org/10.1016/j.biomaterials.2019.119638Human
2019Urine CellsLiu, G et al. (2019) Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Stem Cell Rev and Rep p 1-30, November 23, 2019. Doi.org/10.1007/s12015-019-09935-xHuman
2019FibroblastBjørlykke Y, et al (2019) Reprogrammed Cells Display Distinct Proteomic Signatures Associated with Colony Morphology Variability. Stem Cells International, Volume 2019, Article ID 8036035, November 18, 2019. Doi.org/10.1155/2019/8036035Human
2019PBMCKachamakova-Trojanowska N, et al (2019) Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young. Cells 2019, 8, 1440; November 14, 2019. doi: 10.3390/cells8111440Human
2019FibroblastCozzi A, et al (2019) Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging. Stem Cell Reports, Vol 13, Issue 4, 12 November 2019, Pages 832-846. Doi.org/10.1016/j.stemcr.2019.09.002Human
2019Urinary cellsSong J, et al (2019) Dysregulation of neuron differentiation in an autistic savant with exceptional memory. Molecular Brain, Vol 12, Article number 91, November 7, 2019. Doi.org/10.1186/s13041-019-0507-7Human
2019FibroblastGiorgetti E, et al (2019) Modulation of Microglia by Voluntary Exercise or CSF1R Inhibition Prevents Age-Related Loss of Functional Motor Units. Cell Reports Vol 29, Issue 6, 5 November 2019, Pages 1539-1554.e7. Doi.org/10.1016/j.celrep.2019.10.003Human
2019FibroblastCrutcher E et al (2019) mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome. Scientific Reports 9, Article number: 15935, November 4, 2019. Doi.org/10.1038/s41598-019-52287-2Human
2019FibroblastProndzynsk M, et al (2019) Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol Med (2019) e11115, November 3, 2019 Doi.org/10.15252/emmm.2019111115Human
2019Hepatic organoidsMun SJ, et al (2019) Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. Journal of Hepatology Vol 71, Issue 5, Nov. 2019, p 970-985. Doi.org/10.1016/j.hep.2019.06.030Human
2019FibroblastRodriguez-Traver E, et al (2019) Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene. Stem Cell Res, Vol 40 October 2019, 101578. Doi.org/10.1016/j.scr.2019.101578Human
2019FibroblastPandolfi EC, et al (2019) Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research. Stem Cell Res Vol 40, October 2019, 101576. Doi.org/10.1016/j.scr.2019.101576 Human
2019FibroblastTeinert J, et al (2019) Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47). Stem Cell Res, Vol 40, October 2019, 101575. Doi.org/10.1016/j.scr.2019.101575Human
2019FibroblastDiaz-Guerra E, et al (2019) Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation. Stem Cell Res, Vol 40, October 2019, 101574. Doi.org/10.1016/j.scr.2019.101574Human
2019FibroblastDomingo-Prim J, et al (2019) Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene. Stem Cell Res Vol 40, October 2019, 101570. Doi.org/10.1016/j.scr.2019.101570 Human
2019FibroblastDomingo-Prim J, et al (2019) Generation of an induced pluripotent stem cell line (FRIMOi007-A) derived from an incomplete achromatopsia patient carrying a novel homozygous mutation in PDE6C gene. Stem Cell Res Vol 40, October 2019, 101569. Doi.org/10.1019/j.scr.2019.101569Human
2019FibroblastCerrada V, et al (2019) Derivation of a human DOA iPSC line, IISHDOi006-A, with a mutation in the ACO2 gene: c.1999G>A; p.Glu667Lys. Stem Cell Res Vol 40, October 2019, 101566, doi.org/10.1016/j.scr.2019.101566Human
2019Blood cellsLee Y, et al (2019) Generation of a NE https://www.sciencedirect.com/science/article/pii/S1873506119301849STIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease. Stem Cell Res Vol 40 October 2019, 101554, doi.org/10.1016/j.scr.2019.101554 Human
2019PBMCAlari V, et al. 2019 Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations. Stem Cell Res, Vol 40 October 2019, 101553.Doi.org/10.1016/j.scr.2019.101553Human
2019PBMCChiu CC, et al (2019) Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations. Stem Cell Res Vol 40 October 2019, 101552; doi.org/10.1016/j.scr.2019.101552Human
2019FibroblastGe N, et al (2019) Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation. Stem Cell Res Vol 41 December 2019, 101650. Doi.org/10.1016/j.scr.2019.101650Human
2019PBMCLanzi G, et al (2019) Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease. Stem Cell Res Vol 40, October 2019, doi.org/10.016/j.scr.2019.101548 Human
2019PBMCLiu H, et al (2019) Establishment of a Beals syndrome patient-derived human induced pluripotent stem cell line HELPi001-A. Stem Cell Res, Vol 40 October 2019, 101535. Doi.org/10.1016/j.scr.2019.101535Human
2019CellsKo HJ, et al (2019) GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease. J. Clin. Med. 2019, 8, 1751 doi:10.3390/jcm8101751Human
2019Retinal pigment epithelial cellsHuang CY, et al (2019) Human iPSC banking: barriers and opportunities. Journal of Biomedical Science 26:87. Doi.org/10.1186/s2929-019-578-xHuman
2019CD34+ cellsOlivier EN, et al (2019) Differentiation of Baboon (Papio anubis) Induced-Pluripotent Stem Cells into Enucleated Red Blood Cells. Cells 2019, 8(10), 1282, October 19, 2019. Doi.org/10.3390/cells8101282Baboon (Papio Anubis)
2019PBMCCheng YF, et al (2019) Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutation. Stem Cell Res, Vol 40, October 2019 doi.org/10.1016/j.scr.2019.101524Human
2019FibroblastWoersdoerfer P. et al (2019) Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Scientific Reports 9, Article number: 1566, October 30, 201 doi.org/10.1038/s41598-019-52204-7Human
2019Dendritic cells (DC)Horton C, et al (2019) iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Stem Cells Journals October 17, 2019. Doi.org/10.1002/stem.3095Mouse
2019Fibroblast &Woods S, et al (2019) Generation of Human_Induced Pluripotent Stem CellsHuman
2019FibroblastMiklas JW, et al (2019) TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes. Nature communications 10, 4671 October 11, 2019, doi.org/10.1038/s41467-019-12482-1Human
2019PBMCHiramatsu, N et al (2019) An analysis of monocytes and dendritic cells differentiated from human peripheral blood monocyte-derived induced pluripotent stem cells. Med Mol Morphol October 4, 2019 pp1-10. Doi.org/10.1007/s00795-019-00231-8 
2019Adipose-derived fibroblastDutton LC, et al (2019) Inducing Pluripotency in the Domestic Cat (Felis catus). Stem Cells and Development Vol 28, No 19, September 26,2019, doi/10.1089/scd.2019.0142Felius catus (Domestic Cat)
2019PBMCShlevkov E, et al (2019) A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport. Cell Reports Vol 28, Issue 12, 17 September 2019, Pages 3224-3237.e5, doi.org/10.1016/j.celrep.2019.08.035 Human
2019FibroblastLeibel SL, et al (2019) Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy. Scientific Reports, September 17, 2019, 9: 13450. Doi.org/10.1038/s41598-019-49696-8Human
2019FibroblastErkilic N, et al (2019) A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia. Cells, September 11, 2019, Cells 2019, 8, 1068; doi:10.3390/cells8091068Human
2019Blood cellsXingjun X, et al (2019) CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells. Annals of Hematology pp 1-11. September 11, 2019. Doi.org/10.1007/s00277-019-03763-2Human
2019FibroblastTiihonen J, et al (2019) Sex-specific transcriptional and proteomic signatures in schizophrenia. Nature communications, September 2, 2019, doi.org/10.1038/s4146-019-11797-3Human
2019Cardiac cellsPianezzi E, et al (2019) Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes. BBA, Molecular Cell Research 28 August 2019, 118538, doi.org/10.1016/j.bbamcr.2019.118538Human
2019CellsKreutzer J, et al (2019) Pneumatic unidirectional cell stretching device for mechanobiological studies of cardiomyocyte. Biomechanics and Modeling in Mechanobiology, p. 1-13, August 23, 2019, doi.org/10.1007/s10237-019-01211-8Human
2019Blood cells and fibroblastsPatel AM, et al (2019) Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes. Translational Psychiatry, Vol 9, Article Number 200, August 21, 2019 doi.org/10.1038/s41398-019-0535-1 Human
2019Autosomal dominant osteopetrosis type II (ADO2) cellsOu M, et al (2019) Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells. Stem Cell Research & Therapy Vol 10, Article number: 251, August 10, 2019, doi.org10/.1186/s13287-019-1369-8Human
2019Antigen-specific T-cellsNishimura T, et al (2019) Human iPSC Generation from Antigen-Specific T Cells. In Vitro Differentiation of T-cells pp 53-57, August 9, 2019Human
2019FibroblastAnnunziata I, et al (2019) MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat. Nature communications 10, Article number 3626, August 9, 2019, doi.org/10.1038/s41467-019-11568-0Human
2019FibroblastDe Angelis MT, et al (2019) Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus. J Cell Mol Med. 2019; 23:7382–7394 DOI: 10.1111/jcmm.14598Human
2019CD4+cellsCarbonell AU, et al (2019) Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome. Nature communications, August 6, 2019, Article number: 3529. Doi.org/10.1038/s41467-019-11437Human
2019CellsHuebscher D, et al (2019) A High-Throughput Method as a Diagnostic Tool for HIV Detection in Patient-Specific Induced Pluripotent Stem Cells Generated by Different Reprogramming Methods. Stem Cells International Volume 2019, Article ID 2181437, August 5, 2019 doi.org/10.1155/2019/2181437Human
2019LymphoblastoidPoulin H, et al (2019) Differentiation of lymphoblastoid-derived iPSCs into functional cardiomyocytes, neurons and myoblasts Vol 516, Issue 1, BBRC, 13 August 2019, Pages 222-228 doi.org/10.1016/j.bbrc.2019.05.176 Human
2019Epidermal KeratinocytesKolundzic N, et al (2019) Induced pluripotent stem cell line heterozygous for p.R501X mutation in filaggrin: KCLi003-A. Stem Cell Res Vol 40 August 2019, 101527.Doi.org/10.1019/j.scr.2019.101527Human
2019PBMCSchuster J, et al (2019) Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations. Stem Cell Res Vol 39, August 2019, 101523 doi.org/10.1016/j.scr.2019.101523Human
2019FibroblastDiaz Guerra E, et al (2019) A collection of four integration-free iPSC lines derived from diagnosed sporadic Alzheimer's disease patients with different APOE alleles. Stem Cell Res Vol 39 August 2019, 101522 doi.org/10.1016/j.scr.2019.101522Human
2019PBMCBozaoglu K, et al (2019) Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder Stem Cell Res, Vol 39 August 2019, 101516 doi.org/10.1016/j.scr.2019.101516Human
2019PBMCGatinois V, et al (2019) Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere length. Stem Cell Res Vol 39 August 2019, 101515 doi.org/10.1016/j.scr.2019.101515Human
2019Fibroblast line GM13716Kozlowska E, et al (2019) Generation of human iPS cell line IBCHi001-A from dentatorubral pallidoluysian atrophy patient's fibroblasts. Stem Cell Res Vol 39, August 2019, 101512 Doi.org/10.1019/j.scr.2019.101512Human
2019FibroblastCarreira-Arribas L et al, (2019) Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene. Stem Cell Res Vol 39, August 101503Human
2019FibroblastGe N, et al (2019) Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B). Stem Cell Res Vol 39, August 2019, doi.org/10.1016/j.scr.2019.101502 Human
2019FibroblastYang S, et al (2019) An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene. Stem Cell Res Vol 39, August 101496 doi.org/10.1016/j.scr.2019.101496Human
2019PBMCBai X, et al (2019) Generation of an integration-free induced pluripotent stem cell line (FDEENTi003-A) from a patient with pathological myopia. Stem Cell Res, Vol 39 August 101495 doi.org/10.1016/j.scr.2019.101495 Human
2019FibroblastTongkobpetch S, et al (2019)Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus. Stem Cell Res, Vol 39 August 101493 doi.org/10.1016/j.scr.2019.101493 Human
2019ErythroblastGubert F, et al (2019) Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient. Stem Cell Res, Vol 39 August 2019, 101490 doi.org/10.1016/j.scr.2019.101490 Human
2019Bone marrow mesenchymal stromal cells (MSCs)De Almeida Sampaio GL, et al (2019) Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency. Stem Cell Res, Vol 39 August 101488, doi.org/10.1016/j.scr.2019.101488Human
2019PBMCNetsrithong R, et al (2019) Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual. Stem Cell Res, Vol 39, August 2019, 101487 doi.org/10.1016/j.scr.2019.101487Human
2019FibroblastTantarungsee N, et al (2019) Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia Stem Cell Res, Vol 38, July 2019, 101486 doi.org/10.1016/j.scr.2019.101486 Human
2019FibroblastErkilic N, et al (2019) Generation of a human iPSC line, INMi003-A, with a missense mutation in CRX associated with autosomal dominant cone-rod dystrophy. Stem Cell Res Vol 38, July 2019, 101478, doi.org/10.1016/j.scr.2019.101478 Human
2019FibroblastErkilic N, et al (2019) Generation of a human iPSC line, INMi004-A, with a point mutation in CRX associated with autosomal dominant Leber congenital amaurosis. Stem Cell Res Vol 38, July 2019, 101476 doi.org/10.1016/j.scr.2019.101476 
2019Bone-marrow mesenchymal stem cells (MSC)Okur FV, et al (2019) Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods. Stem Cell Research Research & Therapy, Vol 10, 211, July 17, 2019.Doi.org/10.1186/s13287-019-1316-8Human
2019CellsOlivier EN, et al (2019) PSC-RED and MNC-RED: Albumin-free and low-transferrin robust erythroid differentiation protocols to produce human enucleated red blood cells. J.Exphem, Vol 75, July 2019, Pages 31-52.e15 doi.org/10.1016/j.exphem.2019.05.006Human
2019PBMCRonald Ng, et (2019) Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation. JCI Insight, July 25, 2019 10.1172/jci.insight.128643Human
2019CD34+-derived from PBMCOkumura T, et al (2019) Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector Stem Cell Research & Therapy 10, 185, June 24, 2019 doi.org/10.1186/s13287-019-1273-2Human
2019CD71+-derived from PBMCBlinova K, et al (2019) Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs. Clin Transl Sci (2019) 12, 687–697, June 24, 2019. doi:10.1111/cts.12674Human
2019CellsBooth HDE, et al (2019) RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2G2019S Parkinson's iPSC-derived astrocytes. Neurobiology of Disease Vol. 129, Sept. 2019, p.56-66, doi.org/10.1016/j.nbd.2019.05.006Human
2019PBMCYu SJ, et al (2019) NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats. Brain Research 1719 15 September 2019, Pages 124-132 Doi.org/10/1016/j.brainres.2019.05.040.Human
2019FibroblastVakili D, (2019) A Pipeline to Compare the Differential Splicing and Gene Expression Between iPSC Cells Derived from Patients and Healthy Controls. Thesis, UCL Institute for Child Health. iPSC-Project-Diss-230418.DVHuman
2019FibroblastPolonen RP, (2019) Modelling and Drug Responses in CPVT Patient-Specific hiPSC-derived Cardiomyocyte. Tampere University Dissertations 56, May 31, 2019Human
2019FibroblastSchuster J, et al (2019) Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations. Stem Cell Res 38 101474, May 30, 2019, doi.org/10.1016/j.scr.2019.101474Human
2019CellsCornacchia D, et al (2019) Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs. Cell Stem Cell, May 30, 2019, doi.org/10.1016/j.stem.2019.05.001Human
2019PBMCGarcia-Delgado AB, et al (2019) Generation of a human iPS cell line (CABi003-A) from a patient with age related macular degeneration carrying the CFH Y402H polymorphism. Stem Cell Res 38 101473, May 28, 2019, doi.org/10.1016/j.scr.2019.101473 Human
2019FibroblastZabulica M, et al (2019) Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes. Stem Cells Development, May 24, 2019, doi.org/10.1089/scd.2019.0064Human
2019FibroblastLopez-Marquez A, et al (2019) Generation and characterization of a human iPSC line (UAMi004-A) from a patient with propionic acidemia due to defects in the PCCB gene. Stem Cell Res 38, 101469, May 22, 2019, doi.org/10.1016/j.scr.2019.101469Human
2019CellsMacArthur CC, et al (2019) Generation and comprehensive characterization of induced pluripotent stem cells for translational research. Regenerative Medicine doi.org/10.2217/rme-2018-0148Human
2019FibroblastDomingo-Prim J, et al (2019) Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene. Stem Cell Res 101468, May 22, 2019, doi.org/10.101016/j.scr.2019.101468Human
2019FibroblastEsteve J, et al (2019) Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1. Stem Cell Res 101467, May 21, 2019, doi.org/10.1016/j.scr.2019.101467Human
2019Urine-derived cellsYan X, et al (2019) EstablishmentofCSUASOi001-A, anon-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutation. Stem Cell Res 38, 101466, May 17, 2019, doi.org/10.1016/j.scr.2019.101466Human
2019FibroblastBaskfield A, et al (2019) An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pickdisease type A patient carrying a heterozygous p.L302P (c.905 T > C) mutation in the SMPD1gene. Stem Cell Res 38,101461, May 15, 2019, doi.org/10.1016/j.scr.2019.10461Human
2019CD34+Gunes C, et al (2019) Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator. Stem Cell Reports, Vol. 12, 1–15, May 14, 2019, doi.org/10.1016/j.stemcr.2019.03.012Human
2019KeratinocytesKolundzic N, et al (2019) Induced pluripotent stem cell line heterozygous for p.R2447X mutation in filaggrin: KCLi002-A. Stem Cell Res 38, 101461, May 13, 2019, doi.org/10.1016/j.scr.2019.101462Human
2019Activated & expanded T-cells from PBMCZeng J, et al (2019) Derivation of mimetic __ T cells endowed with cancer recognition receptors from reprogrammed __ T cell . PLoS One 14(5): e0216815 May 9, 2019 doi.org/10.1371/journal.pone.0216815Human
2019PBMCBai X, et al (2019) Establishment of an induced pluripotent stem cell line (FDEENTi002-A) from a patient with Best's disease carrying c.888C_>_A mutation in BEST1 gene. Stem Cell Res 101459, May 9, 2019 doi.org/10.1016/j.scr.2019.101459Human
2019FibroblastBolinches-Amorós A, et al (2019) Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling Stem Cell Res 38, 101455, May 4, 2019, doi.org/10.1016/j.scr.2019.101455Human
2019PBMCGubert F, et al (2019) Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects Stem Cell Res 37 101448, May 4, 2019, doi.org/10.1016/j.scr.2019101448Human
2019CD34+Beke A, et al (2019) Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia. Haematologica 104, May 2, 2019; doi:10.3324/haematol.2018.208488Human
2019FibroblastPontis J, et al (2019) Hominoid-Specific Transposable Elements and KZFPs Facilitate Human Embryonic Genome Activation and Control Transcription in Naive Human ESCs. Cell Stem Cell 24, 724–735, May 2, 2019 doi.org/10.1016/j.stem.2019.03.012Human
2019FibroblastSpyrou J, et al (2019) Metabolomic and transcriptional analyses reveal atmospheric oxygen during human induced pluripotent stem cell generation impairs metabolic reprogramming. Stem Cells April 20, 2019; doi.org/10.1002/stem.3029Human
2019PBMCLin HI, et al (2019) Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation. Stem Cell Res 37, 101447, May 2019, doi.org/10.1016/j.scr.2019.101447Human
2019PBMCMontes R, et al (2019) GENYOi004-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with autism-related ADNP syndrome carrying a pTyr719*mutation. Stem Cell Res 37 101446; April 22, 2019; doi.org/10.1016/j.scr.2019101446Human
2019CD34+Donada A, et al (2019) Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity. Blood 133(16):1778-1788; April 19, 2019; doi.org/10.1182/blood-2018-07-861427.Human
2019FibroblastMonzo Al, et al (2019) Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene. Stem Cell Res 37, 101438, April 15, 2019, doi.org/10.1026/j.scr.2019.101438Human
2019FibroblastHiroso T, et al (2019) ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. JClin Invest; 129(5):2145-2162, April 15, 2019 doi.org/10.1172/JCI79990Human
2019FibroblastSobol, M, et al. (2019) Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions Mol Neurobiol 1585-3. April 13, 2019 doi.org/10.1007/s12035-019-1585-3Human
2019FibroblastBaskfield A, et al (2019) Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation ofp.L43_A44delLA in theSMPD1gene. Stem Cell Res 37, 101436, April 12, 2019, doi.org/10.1016/j.scr.2019.101436Human
2019FibroblastLenz D, et al (2019) Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations inSCYL1. Stem Cell Res 37, 101428, March 22, 2019, doi.org/10.1016/jscr.2019.101428Human
2019FibroblastYeon GB, et (2019) Generation of an induced pluripotent stem cell (iPSC) line from a 42-year-old adult cerebral type X-linked adrenoleukodystrophy (X-ALD) patient. Stem Cell Res 36, 101425, March 21, 2019, doi.org/10.1016/j.scr.2019.101425Human
2019PBMCDe La Cerda Bm, et (2019) Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31gene. Stem Cell Res 36, 101426, March 20, 2019, doi.org/10.1016/j.scr.2019.101426Human
2019FibroblastSoeda S, et al (2019) Neuronal differentiation defects in induced pluripotent stem cells derived from a Prader-Willi syndrome patient. Neuroscience Letters 703, 162-167, March 19, 2019; doi.org/10.2016/j.neulet.2019.03.029Human
2019KeratinocytesKolundzic N, et al (2019) Induced pluripotent stem cell (iPSC) line from an epidermolysis bullosa simplex patient heterozygous for keratin 5 E475G mutation and with the Dowling Meara phenotype. Stem Cell Res 37, 101424, March 14, 2019, doi.org/10.1016/j.scr.2019.101424Human
2019FibroblastWei X, et al (2019) Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells Sci. Adv. 2019; 5: eaau7887 13 March 2019, DOI: 10.1126/sciadv.aau7887Human
2019FibroblastOrtuño-Costela M, et al (2019) Derivation of an aged mouse induced pluripotent stem cell line, IISHDOi005-A. Stem Cell Research 2019, March 12, 36:101418, doi.org/10.1016/j.scr.2019.101418 Human
2019FibroblastJung-Klawitter S, et al (2019) Generation of 2 iPSC clones from a patient with DNAJC12 deficiency: DHMCi003-A and DHMCi003-B. Stem Cell Res 2019, March 8, 36: 101402, doi.org/10.2016/j.scr.2019.101402Human
2019FibroblastHosaka C, et al (2019) Induced pluripotent stem cell_derived melanocyte precursor cells undergoing differentiation into melanocytes, Wiley Online Library March 6, 2019doi.org/10.1111/pcmr.12779Human
2019Aortic endothelial cellsOng SB, et (2019) Calpain Inhibition Restores Autophagy and Prevents Mitochondrial Fragmentation in a Human iPSC Model of Diabetic Endotheliopathy. Stem Cell Reports Vol. 12, 597–610 March 5, 2019, doi.org/10.2016/j.stemcr.2019.01.017Human
2019Hematopoietic stem cellsWang K, et al (2019) Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells Cell Reports 26, 2580–2592 March 5, 2019 doi.org/10.1016/j.celrep.2019.02.021Human
2019Urine-derived cellsChen X, et al (2019) Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds Cell Death and Disease (2019) 10:220, 220, March 5, 2019 doi.org/10.1038/s41419-019-1461-0Human
2019FibroblastRiera M, et al (2019) Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations. Stem Cell Res March 2019, 101385, doi.org/10.1016/j.scr.2019.101385Human
2019FibroblastClippinger SR, et al (2019) Disrupted Mechanobiology Links the Molecular and Cellular 2 Phenotypes in Familial Dilated Cardiomyopathy dx.doi.org/10.1101/555391Human
2019PBMCMajolo F, et al (2019) Important advances in Alzheimer's disease from the use of induced pluripotent stem cells JBC 26:15 doi.org/10.1186/s12929-019-0501-5Human
2019Cord blood CD133+ cellsArellano-Viera E, et al (2019) Generation of two transgene-free human iPSC lines from CD133+ cord blood cells. Stem Cell Res 36 (2019) 101410, Feb 28. 2019, doi.org/10.2016/j.scr.2019.101410Human
2019FibroblastLi X, et al (2019) Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1. Stem Cell Res 36 (2019) 101414, Feb.2; doi.org/10.1016/j.scr.2019.101414 Human
2019FibroblastsLi R, et al (2019) Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene Stem, Feb. 15, 2019, Cell Res 36 101408 doi.org/10.1016/j.scr.2019.101408Human
2019Activated T-cellsDattola E, et al (2019) Development of 3D PVA scaffolds for cardiac tissue engineering and cell screening applications 10.1039/C8RA08187E (Paper) Feb 14, 2019, RSC Adv., 9, 4246-4257Human
2019FibroblastRiera M, et al (2019) Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations. Stem Cell Res 36 (2019) 101389 doi.org/10.1016/j.scr.2019.101389 Human
2019FibroblastCarrio M, et al (2019) Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas. Stem Cell Reports Vol 11, 411-426, February 12, 2019, doi.org/10.2016/jstemcr2019.01.001Human
2019FibroblastLenz D, et al (2019) Generation of an iPSC line from a patient with infantile liver failure syndrome 2 due to mutations in NBAS: DHMCi004-A, Feb. 11, 2019;Stem Cell Res 35 (2019) 101398, doi.org/10.1016/j.scr.2019.101398Human
2019CD34+ /PBMCHaase A, et (2019) GMP-compatible manufacturing of three iPS cell lines from human peripheral blood. Stem Cell Res 35 (2019) 10391, doi.org/10.2016/j.scr.2019.101294Human
2019FibroblastsKahounova Z, et (2019) Generation of human iPSCs from fetal prostate fibroblasts HPrF, Feb. 7, 2019, Stem Cell Res 35 (2019) 101405 doi.org/10.2016/j.scr.2019.101405Human
2019Neural cellsChuang CY, et al (2019) Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology, Feb. 4, 2019. Scientific Reports volume 9, Article number: 1166 (2019) doi.org/10.1028/s41598-018-37774-2Human
2019FibroblastMitchell A, et al (2019) Assessment of iPSC teratogenicity throughout directed differentiation toward an alveolar-like phenotype. Stem Cell Res Jan-Feb. 2019, 105: 45-53, doi.org/10/1016/j.diff.2019.01.003Human
2019NeuronsVadodaria KC et (2019) Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons Molecular Psychiatry Jan 30, 2019Human
2019Cardiac progenitor cells (CPCs)Cuillo A, et al (2019) Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration Int. J. Mol. Sci. Jan, 29 2019, 20(3), 468; doi.org/10.3390/ijms20030468Human
2019FibroblastsLin DS, et al. (2019) Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease Cells Jan 19, 2019, 8(1),65; doi.org/10/3390/cells8010065Human
2019Retinal epithelial cellsDong Y, et al (2019) Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides Jan 17, 2019, Journal of International Medical Research 2019, Vol. 47(4) 1717–1730, DOI: 10.1177/0300060519829990Human
2019Renal carcinoma cellsJW Hwang, et al (2019) iPSC-derived Cancer Organoids Recapitulate Genomic and Phenotypic Alterations of c-met-mutated Hereditary Kidney Cancer bioRxiv Jan 11, 2019 doi.org/10.1101/518456.Human
2019T-cellsShigemura T, et al (2019) Mosaicism of an ELANE Mutation in an Asymptomatic Mother Journal of Clinical Immunology (2019) pp 1-6; doi.org/10.1007/s10875-018-0580-1Human
2019KeratinocytesShrestha R, et al (2019) Aberrant hiPSCs Derived from Human Keratinocytes Differentiate into 3D Retinal Organoids that Acquire Mature Photoreceptors Cells, 8, 36; Jan 9, 2019; doi:10.3390/cells8010036Human
2019CellsBaek SK, et al (2019) A Rho-Associated Coiled-Coil Containing Kinase Inhibitor, Y-27632, Improves Viability of Dissociated Single Cells, Efficiency of Colony Formation, and Cryopreservation in Porcine Pluripotent Stem Cells. Cell Reprogram 2019, Jan 8 doi.org.10/1089/cell.2018.0020Porcine
2019Cord blood mononuclear cells (CBMC)Jang Y, et al (2019) Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering; Experimental & Molecular Medicine (2019) 51:3; Jan 7 2019; doi.org/10.1038/s12276-018-0190-2Human
2019FibroblastAuboyer L, et (2019) Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene. Stem Cell Res 34 (2019) 101381Human
2019PBMCVlahos K, et (2019) Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults. Stem Cell Res 34 (2019) 101380; doi.org/10/1016.j.scr.2018.101380Human
2019FibroblastGustavsson N, et al (2019) Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Res 34 (2019) 101373; doi.org/10.1016/j.scr.2018.101373Human
2019PBMCBai X, et al (2019) Establishment of an induced pluripotent stem cell line (FDEENTi001-A) from a patient with pathological myopia. Stem Cell Res 34 (2019) 101369; doi.org/10.1016/j.scr.2018.101369Human
2018PBMCHennig AF, et (2018) Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis. Stem Cell Res Dec. 26, 101367; doi.org/10.1016/j.scr.2018.101367Human
2019FibroblastLi R, et al (2019) Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res 34 (2019) 101362; doi.org/10.1016/j.scr.2018.101362Human
2019FibroblastNavarro AM, et al (2019) Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation. Stem Cell Res 34 (2019) 101356; doi.org/10.1016/j.scr.2018.11.017Human
2019FibroblastLu YQ, et al (2019) Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SPG76). Stem Cell Res 34 (2019) 101354; doi.org/10.1016/j.scr.2018.11.015Human
2019PBMCPotirat P, et al (2019) An integration-free iPSC line (MUSIi008-A) derived from a patient with severe hemolytic anemia carrying compound heterozygote mutations in KLF1 gene for disease modeling. Stem Cell Res 34 (2019) 101344; doi.org/10.1016/j.scr.2018.09.021Human
2018PBMCZhang QJ, et al (2018) Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis Nature Communications 9, 5230, Dec. 7, 2018Human
2018FibroblastTai L, et al (2018) Reprogramming human dermal fibroblast into induced pluripotent stem cells using non-integrative Sendai virus for transduction Malaysian. JPathol 2018; 40(3): 325 – 329Human
2018FibroblastBaulier E, et al (2018) Generation of a human Ocular Albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Res 33 (2018) 274-277; doi.org/10.1016/j.scr.2018.11.016Human
2018PBMCMohanty S, et (2018) Generation of Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Peripheral Blood Mononuclear Cells of Patients With Atrial Fibrillation Circulation, Nov. 5. 2018, 138; A11444Human
2018PBMCWu S, et (2018) Induced Pluripotent Stem Cells Promote Retinal Ganglion Cell Survival After Transplant IOVS 2018; March, 2018; 59:1571-1576; doi:10.1167/iovs.17-23648Human
2018PBMCEckford PDW, et al. (2018) The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF JCF 2018; March 31; JCF-01643; doi.org/10.1016/j.jcf.2018.03.013Human
2018FibroblastsBattrawy IE, et al. (2018) Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. JAm Heart Assoc. 2018; March 24; 7:e0077394; doi.org/10.1161/JAHA.117.0077394 Human
2018cellsSato C, et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System Neuron 2018; March 21; 97:1284-1298; doi.org/10.1016/j.neuron.2018.02.015Human
2018FetusFerrer CM, et al. (2018) An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality. Genes & Dev. 2018; March 19; 1-3; doi: 10.1101/gad.307330.117Human
2018N/AUlmer BM, et al (2018) Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes. Stem Cell Reports 2018 Mar 13;10(3):834-847. doi: 10.1016/j.stemcr.2018.01.039. Epub 2018 Mar 1.Human
2018Urine cellsSan H, et al (2018) Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human. Stem Cell Res 2018; March 09; 29:28-31; doi.org/10.1016/j.scr.2018.03.002Human
2018PBMCGriscelli F, et al (2018) Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion. Stem Cell Res 2018; March 07; 29:42-45; doi.org/10.1016/j.scr.2018.03.012Human
2018FibroblastsWu YT, et al (2018) Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome. Stem Cell Res 2018 Mar;27:10-14. doi: 10.1016/j.scr.2017.12.013. Epub 2017 Dec 19.Human
2018PBMCNavara CS, et al. (2018) Optimization of culture conditions for the derivation and propagation of baboon (Papio anubis) induced pluripotent stem cells. PLoS One 2018 Mar 1;13(3):e0193195. doi: 10.1371/journal.pone.0193195. eCollection 2018Baboon
2018FibroblastsWattanapanitch M, et al (2018) Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar fibroblasts using Sendai viral vectors. Stem Cell Res 2018 Mar;27:105-108. doi: 10.1016/j.scr.2018.01.013. Epub 2018 Jan 9.Human
2018FibroblastsMarote A. et al (2018) Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene. Stem Cell Res 2018 Mar;27:90-94. doi:10.1016/j.scr.2018.01.006. Epub 2018 Jan 4.Human
2018FibroblastsMarote A, et al (2018) Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease. Stem Cell Res 2018 Mar;27:82-85. doi: 10.1016/j.scr.2018.01.007. Epub 2018 Jan 4.Human
2018FibroblastsSavchenko E, et al (2018) Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease. Stem Cell Res 2018 Mar;27:78-81. doi: 10.1016/j.scr.2018.01.002. Epub 2018 Jan 4.Human
2018FibroblastsRuss K, et al. (2018) Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation. Stem Cell Res 2018 Mar;27:61-64. doi: 10.1016/j.scr.2018.01.001. Epub 2018 Jan 4.Human
2018PBMCLuo Y, et. (2018) Generation of an induced pluripotent stem cell line from an adult male with 45,X/46,XY mosaicism. Stem Cell Res 2018 Mar;27:42-45. doi: 10.1016/j.scr.2018.01.003. Epub 2018 Jan 5.Human
2018FibroblastsIannielli A, et al. (2018) Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models Cell Rep 2018 Feb 20;22(8):2066-2079. doi: 10.1016/j.celrep.2018.01.089.Human
2018FibroblastsKreienkamp R, et (2018) A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by Progerin. Cell Rep 2018 Feb 20;22(8):2006-2015. doi: 10.1016/j.celrep.2018.01.090.Human
2018FibroblastsKroeger H, et al (2018) The unfolded protein response regulator ATF6 promotes mesodermal differentiation Sci.Signal.2018 Feb 13;11(517). pii: eaan5785. doi: 10.1126/scisignal.aan5785.Human
2018FibroblastsSahakyan V, et al (2018) Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model Sci. Rep 2018 Feb 13;8(1):2942. doi: 10.1038/s41598-018-21103-8.Human
2018CD34+ cellsYe L, et al. (1018) MiR-126 enhances VEGF expression in induced pluripotent stem cell-derived retinal neural stem cells by targeting spred-1. Int J Clin Exp Pathol 2018; Feb 01; 11(2):1023-1030.Human
2018PBMCLong C, et (2018) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci Adv 2018 Jan 31;4(1):eaap9004. doi: 10.1126/sciadv.aap9004. eCollection 2018 Jan.Human
2018FibroblastsRussell OM, et al (2018) Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo. Scientific Reports 2018; Jan 29; 8:1799 DOI:10.1038/s41598-018-20064-2.Human
2018FibroblastsRomano G, et al. (2018) Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses. Sci Rep. 2018 Jan 29;8(1):1809. doi: 10.1038/s41598-018-19802-3.Human
2018EBV immortalized lymphoblastoidsMartineau L, et al (2018) Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)200 expansion in the DMPK gene: CHUQi001-A. Stem Cell Res 2018 Jan;26:103-106. doi: 10.1016/j.scr.2017.12.010. Epub 2017 Dec 16.Human
2018FibroblastsKucherenko MM, et (2018) Stress-dependent miR-980 regulation of Rbfox1/A2bp1 promotes ribonucleoprotein granule formation and cell survival. Nat Commun 2018 Jan 22;9(1):312. doi: 10.1038/s41467-017-02757-w.Human
2018Keratinocytes/HairSulkowski M, et (2018) Introduction of Exogenous HSV-TK Suicide Gene Increases Safety of Keratinocyte-Derived Induced Pluripotent Stem Cells by Providing Genetic "Emergency Exit" Switch. Int J Mol Sci 2018 Jan 9;19(1). pii: E197. doi: 10.3390/ijms19010197.Human
2018FibroblastsKim S, et al. (2018) GBA1 deficiency negatively affects physiological _-synuclein tetramers and related multimers. PNAS 2018; Jan 08;DOI:10.1073/pnas.1700465115.Human
2017FibroblastsRodriguez-Madoz, JR et al (2017) Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PLoS One 2017 Dec 27;12(12):e0190275. doi: 10.1371/journal.pone.0190275. eCollection 2017.Human
2017FibroblastsHe J, et (2018) Generation of Induced Pluripotent Stem Cells from Patients with COL3A1 Mutations and Differentiation to Smooth Muscle Cells for ECM-Surfaceome Analyses. Methods Mol Biol 2018;1722:261-302. doi: 10.1007/978-1-4939-7553-2_17.Human
2017FibroblastsHoffman GE, et al (2017) Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains Nat. Commun 2017 Dec 20;8(1):2225. doi: 10.1038/s41467-017-02330-5.Human
2017FibroblastsWalsh P, et al (2017) Defined Culture Conditions Accelerate Small-molecule-assisted Neural Induction for the Production of Neural Progenitors from Human-induced Pluripotent Stem Cells. Cell Transplant 2017 Dec;26(12):1890-1902. doi: 10.1177/0963689717737074.Human
2017Dental mesenchymal stem cells (SCAP, DPSCs)Tan X, et al. (2017) Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes. Biochem Biophys Res Comm. In press 05 Dec 17. Human
2017Dermal fibroblastsParrotta E, et al. (2017) Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy. Stem Cell Research & Therapy 2017 8:271 https://doi.org/10.1186/s13287-017-0720-1. Human
2017Peripheral bloodRybová J, et al. (2017) Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II. JInherit Metab Dis. 2017 Nov 22. doi: 10.1007/s10545-017-0108-5.Human
2017Dermal fibroblasts and T-cellsOksanen M, et al. (2017) PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease. Stem Cell Reports 2017 Dec 12;9(6):1885-1897. doi: 10.1016/j.stemcr.2017.10.016. Human
2017FibroblastsYou YR, et al. (2017) Generation of induced pluripotent stem cell (iPSC) line from a 21-year-old X-linked adrenoleukodystrophy (X-ALD) patient. Stem Cell Res 2017 Dec;25:136-138. doi: 10.1016/j.scr.2017.10.016. Human
2017PBMCsHsu YH, et al. (2017) Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene. Stem Cell Res 2017 Dec;25:245-249. doi: 10.1016/j.scr.2017.10.024. Human
2017PBMCsXu T, et al. (2017) Generation of integration-free induced pluripotent stem cell line (NJMUi001-A) from a phenylketonuria patient. Stem Cell Res 2017 Dec;25:179-182. doi: 10.1016/j.scr.2017.11.008. Human
2017Dermal fibroblastsWang Y, et al. (2017) Generation of induced pluripotent stem cell line (ZZUi005-A) from a 21-year-old patient with a novel RAB39B gene mutation in X-linked juvenile parkinsonism. Stem Cell Res 2017 Dec;25:132-135. doi: 10.1016/j.scr.2017.10.021.Human
2017Dermal fibroblastsWang Z, et al. (2017) Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation. Stem Cell Res 2017 Dec;25:213-216. doi: 10.1016/j.scr.2017.10.025. Human
2017PBMCsLin CH, et al. (2017) Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation. Stem Cell Res 2017 Dec;25:123-127. doi: 10.1016/j.scr.2017.10.020. Human
2017PBMCsLee JJ, et al. (2017) Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation. Stem Cell Res 2017 Dec;25:83-87. doi: 10.1016/j.scr.2017.10.026. Human
2017Urine epithelial cellsCristo F, et al. (2017) Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration. Stem Cell Res 2017 Dec;25:152-156. doi: 10.1016/j.scr.2017.10.019. Human
2017PBMCsFujimori K, et al. (2017) Escape from Pluripotency via Inhibition of TGF-_/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells. Stem Cell Reports 2017 Nov 14;9(5):1675-1691. doi: 10.1016/j.stemcr.2017.09.024. Human
2017Dermal fibroblastsFu S, et al. (2017) Generation of human-induced pluripotent stem cells from burn patient-derived skin fibroblasts using a non-integrative method. Int J Mol Med. 2018 Jan;41(1):87-94. doi: 10.3892/ijmm.2017.3206. Human
2017Dermal fibroblastsSon D, et al. (2017) Generation of two induced pluripotent stem cell (iPSC) lines from X-linked adrenoleukodystrophy (X-ALD) patients with adrenomyeloneuropathy (AMN). Stem Cell Res 2017 Dec;25:46-49. doi: 10.1016/j.scr.2017.10.003. Human
2017Hair follicle keratinocytesAdhya D, et al. (2017) Understanding role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach. J Neuroendocrinol 2017 Oct 12. doi: 10.1111/jne.12547. [Epub ahead of print] Human
2017PBMCsHo MC, et al. (2017) Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2. Stem Cell Res 2017 Dec;25:38-41. doi: 10.1016/j.scr.2017.10.005. Human
2017Dermal fibroblastsDuncan G, et al. (2017) Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Stem Cells Dev. 2017 Dec 1;26(23):1695-1705. doi: 10.1089/scd.2017.0172. Human
2017Dermal fibroblastsTerray A, et al. (2017) Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation. Stem Cell Res 2017 Dec;25:26-29. doi: 10.1016/j.scr.2017.10.007. Human
2017Dermal fibroblastsRusso FB, et al. (2017) Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells. Biol Psychiatry. 2017 Oct 3. pii: S0006-3223(17)32009-7. doi: 10.1016/j.biopsych.2017.09.021. Human
2017Dermal fibroblastsRomero-Moya D, et al. (2017) Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q10 deficiency harboring a heterozygous mutation in COQ4 gene. Stem Cell Res 2017 Oct;24:144-147. doi: 10.1016/j.scr.2016.09.007. Epub 2016 Sep 16. Human
2017PBMCsHuang CY, et al. (2017) Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1. Stem Cell Res 2017 Oct;24:139-143. doi: 10.1016/j.scr.2017.09.004. Human
2017PBMCsGriscelli F, et al. (2017) Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene. Stem Cell Res In press 14 Sep 17. Human
2017Dermal fibroblastsWu J, et al. (2017) Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi). Stem Cell Res 2017 Oct; 24:102-105 https://doi.org/10.1016/j.scr.2017.08.020. Human
2017Amniotic fluid cellsYan J, et al. (2017) Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease. Hemoglobin 2017 Published online 24 Aug 2017 http://dx.doi.org/10.1080/03630269.2017.1353523.Human
2017FibroblastsZurita-Diaz F, et al. (2017) Establishment of a human DOA 'plus' iPSC line, IISHDOi003-A, with the mutation in the OPA1 gene: c. 1635C> A; p. Ser545Arg. Stem Cell Res 2017 Oct; 24:81-84 https://doi.org/10.1016/j.scr.2017.08.017. Human
2017Dermal fibroblastsWeir G, et al. (2017) Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source. Brain, awx201 https://doi.org/10.1093/brain/awx201. Human
2017Adipose tissue-derived mesenchymal multipotent stromal cellsKhudiakov A, et al. (2017) Generation of iPSC line from desmin-related cardiomyopathy patient carrying splice site mutation of DES gene. Stem Cell Res 2017 Oct; 24:77-80 https://doi.org/10.1016/j.scr.2017.08.015. Human
2017Adipose tissue-derived mesenchymal multipotent stromal cellsKhudiakov A, et al. (2017) Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene. Stem Cell Res 2017 Oct; 24:84-88 https://doi.org/10.1016/j.scr.2017.08.014. Human
2017PBMCsMora C, et al. (2017) Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p. D322H mutation. Stem Cell Res 2017 Oct; 24:29-32 https://doi.org/10.1016/j.scr.2017.08.009. Human
2017PBMCsMora C, et al. (2017) Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p. M200V mutation. Stem Cell Res 2017 Oct; 24:8-11 https://doi.org/10.1016/j.scr.2017.08.007. Human
2017CD34+ cellsLimia CEG, et al. (2017) Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation. Stem Cell Res 2017 Oct; 24:16-20 https://doi.org/10.1016/j.scr.2017.08.006. Human
2017Dermal fibroblastsTerray A, et al. (2017) Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene. Stem Cell Res 2017 Oct; 24:1-4 https://doi.org/10.1016/j.scr.2017.08.003. Human
2017FibroblastsOrtuño-Costela M (2017) Establishment of a human iPSC line (IISHDOi001-A) from a patient with McArdle disease. Stem Cell Res 2017 Aug;23:188-192. doi: 10.1016/j.scr.2017.07.020. Epub 2017 Jul 28. Human
2017PBMCsGriscelli F, et al. (2017) Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation. Stem Cell Res 2017 Aug;23:178-181. doi: 10.1016/j.scr.2017.07.023. Epub 2017 Jul 25. Human
2017PBMCsBennaceur-Griscelli A, et al. (2017) Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation. Stem Cell Res 2017 Aug;23:154-157. doi: 10.1016/j.scr.2017.07.022. Epub 2017 Jul 22. Human
2017Dermal fibroblastsAlonso-Barroso E, et al. (2017) Generation and characterization of a human iPSC line from a patient with propionic acidemia due to defects in the PCCA gene. Stem Cell Res 2017 Aug; 23:154-157 https://doi.org/10.1016/j.scr.2017.07.022. Human
2017Dermal fibroblastsUhlen E, et al. (2017) Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix. JVis Exp. 2017 Jul 7;(125). doi: 10.3791/56146.Human
2017Dermal fibroblastsTorriano S, et al. (2017) Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy. Hum Mol Genet. 2017 Sep 15;26(18):3573-3584. doi: 10.1093/hmg/ddx244. Human
2017Dermal fibroblastsKlein S, et al. (2017) A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G > A mutation, ISMMSi002-B, for disease modeling. Stem Cell Res 2017 Aug; 23:73-76 https://doi.org/10.1016/j.scr.2017.06.016. Human
2017Dermal fibroblastsAguisanda F, et al. (2017) Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics. Orphanet Journal of Rare Diseases 2017 Jun 28; 12(1):120. doi: 10.1186/s13023-017-0670-9. Human
2017Dermal fibroblastsBrookhauser N, et al. (2017) Long-Term Culture of Self-renewing Pancreatic Progenitors Derived from Human Pluripotent Stem Cells. Stem Cell Reports 2017 Jun 6;8(6):1675-1688. doi: 10.1016/j.stemcr.2017.05.019.Human
2017PBMCsChen Y, et al. (2017) Generation of integration-free induced pluripotent stem cells (GZHMUi001-a) by reprogramming peripheral blood mononuclear cells from a 47, XXX syndrome patient. https://doi.org/10.1016/j.scr.2017.06.002.Human
2017PBMCsBrookhauser N, et al. (2017) Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. https://doi.org/10.1016/j.scr.2017.06.003.Human
2017Stem cells from apical papilla (SCAP) and dental pulp stem cells (DPSC)Tan X, et al. (2017) Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells. PLoS One 2017 May 18;12(5):e0177832. doi: 10.1371/journal.pone.0177832. eCollection 2017.Human
2017Dermal fibroblastsFields MA, et al. (2017) Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells. https://doi.org/10.1371/journal.pone.0177763. Human
2017Dermal fibroblastsUusi-Rauva K, et al. (2017) Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses. Int J Mol Sci2017, 18, 955; doi:10.3390/ijms18050955. Human
2017Dermal fibroblastsGabriel B, et al. (2017) Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders. J Vis Exp 2017 Apr 14;(122). doi: 10.3791/55372.Human
2017PBMCsWarren CR, et al. (2017) Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. Cell Stem Cell 2017 Apr 6;20(4):547-557.e7. doi: 10.1016/j.stem.2017.01.010.Human
2017Dermal fibroblastsTavian D, et al. (2017) Generation of induced pluripotent stem cells as disease modelling of NLSDM. Mol Genet Metab 2017 May;121(1):28-34. doi: 10.1016/j.ymgme.2017.03.009. Epub 2017 Apr 3.Human
2017Dermal fibroblastsChen G, et al. (2017) Derivation of Human-Induced Pluripotent Stem Cells in Chemically Defined Medium. Methods Mol Biol2017;1590:131-137. doi: 10.1007/978-1-4939-6921-0_9.Human
2017Urinary cellsUhm KO, et al. (2017) Generation of human induced pluripotent stem cells from urinary cells of a healthy donor using a non-integration system.. Stem Cell Research 21 (2017) 44–46 https://doi.org/10.1016/j.scr.2017.03.019.Human
2017Cord blood CD34+ cellsHaase A, et al. (2017) Generation of non-transgenic iPS cells from human cord blood CD34+ cells under animal component-free conditions. Stem Cell Research 21 (2017) 71–73 http://dx.doi.org/10.1016/j.scr.2017.03.022.Human
2017Dermal fibroblastsBuonocore F, et al. (2017) Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest 2017 May 1;127(5):1700-1713. doi: 10.1172/JCI91913. Epub 2017 Mar 27.Human
2017PBMCsLi Y, et al. (2017) Abnormal Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Partially Mimicked Development of TSC2 Neurological Abnormalities. Stem Cell Reports 2017 Apr 11;8(4):883-893. doi: 10.1016/j.stemcr.2017.02.020. Epub 2017 Mar 23.Human
2017PBMCsVarga E, et al. (2017) Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD). Stem Cell Research 21 (2017) 16–18 http://dx.doi.org/10.1016/j.scr.2017.03.010. Human
2017Dermal fibroblastsLukovic D, et al. (2017) Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene. Stem Cell Research 21 (2017) 23–25 http://dx.doi.org/10.1016/j.scr.2017.03.007. Human
2017Dermal fibroblastsCoppiello G, et al. (2017) Generation of Macaca fascicularis iPS cell line ATCi-MF1 from adult skin fibroblasts using non-integrative Sendai viruses. Stem Cell Research Volume 21, May 2017, Pages 1–4, https://doi.org/10.1016/j.scr.2017.03.008. Macaque
2017Primary conjunctival cellsGeng Z, et al. (2017) Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. PLoS One2017 Mar 10;12(3):e0173575. doi: 10.1371/journal.pone.0173575. eCollection 2017. Human
2017FibroblastsHunihan L, et al. (2017) Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line. Stem Cell Research 2017 Apr;20:67-69. doi: 10.1016/j.scr.2017.02.017. Epub 2017 Mar 7. Human
2017FibroblastsJung-Klawitter S, et al. (2017) Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1. Stem Cell Research 2017 Apr;20:38-41. doi: 10.1016/j.scr.2017.02.010. Epub 2017 Feb 24. Human
2017FibroblastsBharathan S, et al. (2017) Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation. Stem Cell Research 2017 Apr;20:54-57. doi: 10.1016/j.scr.2017.02.006. Epub 2017 Feb 22.Human
2017Dermal fibroblastsTrevisan M et al. (2017) Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells. Int J Mol Sci 18(1) 206 doi:10.3390/ijms18010206.Human
2016T lymphocytesHashimoto A et al. (2016) Generation of induced pluripotent stem cells from patients With Duchenne muscular dystrophy and their Induction to cardiomyocytes. Int Heart J 57(1):112–7 doi:10.1536/ihj.15-376. Epub.Human
2016PBMCsQuintana-Bustamante O et al. (2016) Generation of patient-specific induced pluripotent stem cell from peripheral blood mononuclear cells by Sendai reprogramming vectors. Methods Mol Biol 2016;1353:1–11 doi:10.1007/7651_2014_170.Human
2016FibroblastsWiley LA et al. (2016) cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness. Sci Rep. 6:30742 doi:10.1038/srep30742.Human
2016Urine epithelial cellsRossbach B et al. (2016) Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai technology. Stem Cell Research 16(2):314–7 doi:10.1016/j.scr.2015.12.018. Epub.Human
2016Fibroblasts, CD34+ cellsSivapatham R et al. (2016) Generation and characterization of patient-specific induced pluripotent stem cell for disease modeling. Methods in Molecular Biology 1353:25–44 doi: 10.1007/7651_2014_157.Human
2015FibroblastsBeers J et al. (2015) A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. Sci Rep. 5:11319 doi:10.1038/srep11319.Human
2015Urine-derived cellsAfzal MZ et al. (2015) Generation of Induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp (95) e52032. doi:10.3791/52032.Human
2015BJ fibroblasts, adult dermal fibroblasts (HDF)Hribar KC et al. (2015) Nonlinear 3D projection printing of concave hydrogel microstructures for long-term multicellular spheroid and embryoid body culture. Lab Chip 15(11):2412–2418 doi:10.1039/c5lc00159e.Human
2015Adult cardiac fibroblastZhang L et al. (2015) Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast. Circulation: Heart Failure 8:156–166 doi:10.1161/CIRCHEARTFAILURE.114a.001317.Human
2015PBMCsSoares FA et al. (2015) Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells using Sendai virus. Methods Mol Biol. 1357:23–31 doi:10.1007/7651_2015_202.Human
2015Dermal fibroblastsLahm H et al. (2015) Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species. Stem Cells 33(2):392–402 doi: 10.1002/stem.1872.Human
2015FibroblastsRao RA et al. (2015) Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci Rep 5:8229 doi:10.1038/srep08229.Human
2015PBMCsMalchenko S et al. (2015) A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells. PLoS One 10(3):e0121707 doi:10.1371/journal.pone.0121707.Human
2014Peripheral mononuclear cellsFujie Y et al. (2014) New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood. PLoS One 9(12):e113052 doi:10.1371/journal.pone.0113052. eCollection 2014.Human and chimpanzee
2014Human mammary epithelial cells (HMECs), primary fibroblastsTokunaga K et al. (2014) Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells. Scientific Reports 4:6996 doi:10.1038/srep06996.Human
2014Primary fibroblastsSchlaeger TM et al. (2014) A comparison of non-integrating reprogramming methods. Nature Biotechnology 33:58–63. doi:10.1038/nbt.3070.Human
2014Amniotic fluid mesenchymal stromal cells (AF-MSCs)Jiang G et al (2014) Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy. Stem Cells and Development 23(21):2613–2625 doi:10.1089/scd.2014.0110.Human
2014Finger-prick blood samplesTan HK et al. (2014) Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. Stem Cells Trans Med 3:586–598 doi:10.5966/sctm.2013-0195.Human
2014Umbilical vein endothelial cellsNishio M et al. (2014) Differentiation of human pluripotent stem cells into highly functional classical brown adipocytes. Methods Enzymol 537:177–97 doi:10.1016/B978-0-12-411619-1.00010-0.Human
2014Adult fibroblastsCourtot AM et al. (2014) Morphological analysis of human induced pluripotent stem cells during induced differentiation and reverse programming. BioResearch Open Access 3(5):206–216 doi:10.1089/biores.2014.0028.Human
2014PBMCsKishino Y et al. (2014) Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions. PLoS One 9(5):e97397 doi:10.1371/journal.pone.0097397.Human
2014Frozen non-cryoprotected dural and scalp fibroblastsSproul AA et al. (2014) Generation of iPSC lines from archived non-cryoprotected biobanked dura mater. Acta Neuropathol Commun 2:4 doi:10.1186/2051–5960-2-4.Human
2014Dermal fibroblastsChestkov IV et al. (2014) Patient-specific induced pluripotent stem cells for SOD1-associated amyotrophic lateral sclerosis pathogenesis studies. Acta Naturae 6(1) 54–60.Human
2014BJ fibroblastsQuintanilla RH Jr et al. (2014) CD44 Is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS ONE 9(1):e85419 doi:10.1371/journal.pone.0085419.Human
2014Peripheral blood T cellsTakamatsu K et al. (2014). Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res 13(3 Pt A):442–53 doi:10.1016/j.scr.2014.10.001.Human
2014FibroblastsChoi IY et al. (2014) Efficient generation human induced pluripotent stem cells from human somatic cells with Sendai-virus. J Vis Exp (86) e51406 doi:10.3791/51406.Human
2014FibroblastsBurridge PW et al. (2014) Chemically defined generation of human cardiomyocytes. Nat Methods 11(8):855-60 doi:10.1038/nmeth.2999.Human
2014Dermal fibroblastsNazor KL et al. (2014) Application of a low cost array-based technique - TAB-Array - for quantifying and mapping both 5mC and 5hmC at single base resolution in human pluripotent stem cells. Genomics 104(5):358–67 doi:10.1016/j.ygeno.2014.08.014.Human
2014FibroblastsWoodard CM et al. (2014) iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. Cell Rep 9(4):1173–82 doi:10.1016/j.celrep.2014.10.023.Human
2013Dermal fibroblastsShang L et al. (2013) ?-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes 63(3):923–933 doi:10.2337/db13-0717.Human
2013FibroblastsJianfeng Lu et al. (2013) Generation of integration-free and region-specific neural progenitors from primate fibroblasts. Cell Rep (5):1580–91 doi:10.1016/j.celrep.2013.04.004. Epub.Human and rhesus monkey
2013CD34+Wang T et al. (2013) Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation. PLoS One 8(11):e81720 doi:10.1371/journal.pone.0081720.Human
2013PBMCChen IP et al. (2013) Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia. Cell Reprogram 15(6):503–13 doi:10.1089/cell.2013.0037. Epub.Human
2013PBMCZhang XB (2013) Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics 11(5):264–74 doi:10.1016/j.gpb.2013.09.001. Epub.Human
2013MultipleBernal JA (2013) RNA based tools for nuclear reprogramming and lineage-conversion: Towards clinical applications. Cardiovasc Transl Res 6(6):956–68 doi:10.1007/s12265-013-9494-8. Epub.Human
2013CD34+ /PBMCYe L et al. (2013) Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai virus vectors. Stem Cells Transl Med 2(8):558-66 doi:10.5966/sctm.2013–0006. Epub.Human
2013PBMCChurko JM et al. (2013) Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol 1036:81–8 doi:10.1007/978-1-62703-511-8_7.Human
2013FibroblastsKahler DJ et al. (2013) Improved methods for reprogramming human dermal fibroblasts using fluorescence activated cell sorting. PLoS One 8(3):e59867 doi: 10.1371/journal.pone.0059867. Epub.Human
2013Blood or FibroblastsLieu PT et al. (2013) Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus. Methods Mol Biol 997:45–56 doi:10.1007/978-1-62703-348-0_5.Human
2013Review articleMalik N et al. (2013) A review of methods of human iPSC derivation. Methods Mol Biol 997:23–33 doi:10.1007/978-1-62703-348-0_3. Review.Human
2013Fibroblasts, keratinocytes and iris pigmented epithelial cellsTucker BA et al. (2013) Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl Med 2(1):16–24 doi:10.5966/sctm.2012-0040. Epub.Human and Mouse
2013FibroblastsHua H et al. (2013) iPSC-derived _ cells model diabetes due to glucokinase deficiency. J Clin Invest doi:10.1172/JCI67638 Epub ahead of print.Human
2013FibroblastsMenendez L et al. (2013) Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc 8(1):203–12. Epub.Human
2012PBMCYang W et al. (2012) iPSC reprogramming from human peripheral blood using Sendai virus mediated gene transfer. StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008–2012.Human
2012BloodDaheron L et al. (2012) Blood - SeV derived fibroblast generated iPSCs. StemBook [Internet] Cambridge (MA): Harvard Stem Cell Institute; 2008–2012.Human
2012CD34+Nishishita N et al. (2012) Generation of virus-free induced pluripotent stem cell clones on a synthetic matrix via a single cell subcloning in the naïve state. PLoS One 2012;7(6):e38389 doi:10.1371/journal.pone.0038389. Epub.Human
2012Skeletal MyoblastsTrokovic R et al. (2012) Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts. Stem Cells Dev 22(1):114–23. Epub.Human
2012Fibroblasts, cord blood cells and peripheral blood cellsKajiwara et al. (2012) Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci USA 109(31):12538–43. Epub.Human
2012Cord blood CD34+ cells and fibroblastsKumano et al. (2012) Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 119(26):6234–42. Epub.Human
2012Nasal epithelial cellsOno M et al. (2012) Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector. PLoS ONE 7(8):e42855 doi:10.1371/journal.pone.0042855.Human
2012FibroblastsKudva et al. (2012) Transgene-free disease-specific induced pluripotent stem cells from patients with Type 1 and Type 2 diabetes. Stem Cells Trans Med doi:10.5966/sctm.2011-0044.Human
2012FibroblastsJin et al. (2012) Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Trans Med doi:10.5966/sctm.2012-0005.Human
2012FibroblastsNakamura N et al. (2012) Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays. Cell Reprogram 14(2):171–85.Human
2012FibroblastsMacArthur C et al. (2012) Generation of human induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int 2012:564612.Human
2012Peripheral bloodSeki T et al. (2012) Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat Protoc 7(4):718–28. doi:10.1038/nprot.2012.015.Human
2011MRC-5Kriks S et al. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature doi:10.1038/nature10648.Human
2011FibroblastsYusa K et al. (2011) Targeted gene correction of _1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478(7369):391–4 doi:10.1038/nature10424.Human
2011Peripheral circulating T cellsSeki T et al. (2011) Derivation of induced pluripotent stem cells from human peripheral circulating T cells. Curr Protoc Stem Cell Biol Chapter 4:Unit4A.3.Human
2011Fibroblasts, CD34+ cord blood cellsNishikawa S et al. (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. PNAS 108(34):14234–14239 doi:10.1073/pnas.1103509108. Epub.Human
2010Fibroblasts,CD34+ cord blood cellsTakayama N et al. (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207(13):2817–30 doi:10.1084/jem.20100844.Human
2010T cellsSeki T et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7(1):11–14 doi:10.1016/j.stem.2010.06.003.Human
2009FibroblastsFusaki N et al. (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85(8):348–362. 

Learn more about CytoTune-iPS Sendai Reprogramming Kits